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ABSTRACT OF DISSERTATION 
 
 
 
NEW DEVELOPMENTS IN CYCLIZED ARSENIC AND ANTIMONY THIOLATES 
 
 
 
There is a continued interest in the properties of arsenic thiolate compounds for 
both industrial and biological uses. Recent discoveries in the medicinal properties of such 
compounds have resulted in a sustained need for the synthesis of new dithiarsolane 
compounds for research as anti-leukemic compounds. Close analogues of the 2-halo 
arsenic dithiolates, namely those with an arsenic-carbon bond instead of an arsenic-halide 
bond, have recently been shown to have some efficacy towards leukemia cells. Based on 
the hydrolytic character and the active role of glutathione with arsenic in vivo, the 
compounds reported here may also have such activity. Arsenic compounds have 
demonstrated biological activity in the literature, thus the hypothesis of this thesis is 
cyclized arsenic thiolates can be synthesized with the appropriate characteristics as to be 
potentially useful medicinal agents as well as provide new structural and reaction 
information. A series of arsenic and antimony di- and trithiolates has been synthesized 
and characterized. Those compounds include 2-chloro-1,3,2-dithiarsolane, 2-bromo-
1,3,2-dithiarsolane, 2-iodo-1,3,2-dithiarsolane, 2-chloro-1,3,2-dithiarsenane, 2-bromo-
1,3,2-dithiarsenane, 2-iodo-1,3,2-dithiarsenane, 3-chloro-4H,7H-5,6-benz-1,3,2-
dithiarsepine, 2-chloro-benzo-1,3,2-dithiarsole, 1,2-bis-dithiarsolan-2-ylmercapto-ethane, 
tris-(pentafluorophenylthio)-arsen, bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)-
benzenesulfide), 2-chloro-benzo-1,3,2-dithiastibole, and bis(2-(1,3,2-benzodithistibol)-
1,2-benzenedithiol. 
 
Elucidation of the pH characteristics of arsenic dithiolates within the human 
toxicity reaction pathway is an area of interest. It has been shown that the aqueous arsenic 
dithiolate stability depends on the size of the ring. 2-Chloro-1,3,2-dithiarsolane has been 
shown to be somewhat stable at both low and high pH as well as neutral pH. 1,2-bis-
Dithiarsolan-2-ylmercapto-ethane is completely stable in a neutral aqueous solution. 
Glutathione does not permanently bind to arsenic even in overwhelming excess.  
 
In particular, these fully characterized compounds determine how reactive the 
As–S and As–Cl linkages are under environmental and biological conditions, and provide 
a source of new reagents to examine in medical applications. Future applications may 
include the incorporation of the reported compounds in filtration and remediation 
technologies with further modification. 
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Chapter 1 
 
Introduction 
 
1.1 Overview 
Arsenic dithiolates first became of interest as a product of the combination 
between arsenic trichloride and 1,2-dithioethane. This reaction was completed as an 
analogous reaction to the poisonous war gas Lewisite (ClCH=CHAsCl2) reacting with a 
vicinal dithiol “cure”. It was the first purposeful and published synthesis establishing a 
route for detoxification of nerve agents like Lewisite. The use of compounds such as 2,3-
dithiopropanol and 2,3-dimercaptosuccinic acid as cures for arsenic poisoning dates back 
to the early 1900’s. Studies on the extensive medicinal properties of arsenic compounds 
beyond Paul Ehrlich’s Salvarsan were not seen as important until recently with the 
resurgence of As2O3 as a therapeutic compound. More recently, analogues of the 2-halo 
arsenic dithiolates, namely those with an arsenic-carbon bond instead of an arsenic-halide 
bond have recently been shown to have some efficacy towards leukemia cells. It is 
speculated that the compounds reported here also have such activity. Based on the fact 
that close analogues of the arsenic compounds reported here have biological activity, it is 
the purpose of this research to synthesize cyclized arsenic thiolates with the appropriate 
characteristics as to be potentially useful as medicinal agents as well as provide new 
structural, characterization and reaction information. 
2 
The compounds reported herein are cyclized arsenic dithiolates with a terminal 
halide, arsenic trithiolates, an antimony dithiolate with a terminal halide, and an antimony 
trithiolate.   
1.1.1 Cancer Treatment with As2O3 and Other Arsenic-containing Compounds 
Arsenic has been used therapeutically for over 2400 years. Organo-arsenicals 
have been studied in terms of their pharmaceutical uses for the last hundred-plus years 
dating back to the early nineteen hundreds. There are pharmaceutical applications based 
on Ehrlich’s use of Salvarsan in the treatment of syphilis. Arsenic trioxide (As2O3) was 
used empirically to treat a variety of disorders, and in 1878, it was reported to reduce 
white blood cell counts in two normal individuals and one with “leucocythemia.” Arsenic 
trioxide is also known as an anti-bacterial and anti-cancer agent.[1] In the 1930s, arsenic 
trioxide was reported to be effective in chronic myelogenous leukemia.  
The medicinal use of arsenic-containing compounds declined during the mid-20th 
century until it was reported from China that patients with acute promyelocytic leukemia 
(APL) who had been treated with arsenic trioxide had a high proportion of hematologic 
responses. The FDA approved the use of arsenic trioxide for relapsed or refractory APL 
in September 2000.[2, 3] However, there is some disagreement in the literature on whether 
or not arsenic induces apoptosis through down-regulation of B cell lines.[4, 5] There is also 
a growing interest in the use of arsenicals for other diseases, such as the use of As2O3 in 
treating malignant lymphoma.[6] It has been published that As2O3 exerts an effect on 
lymphoid neoplasms.[7] Also, the use of arsenical derivatives such as melarsoprol may be 
effective in the treatment of multiple myeloma.[8] In 2003, organic phenyl arsonic acid 
derivatives were synthesized and shown to have antiluekemic activity in vitro.[9] In a 
3 
recent publication, it was shown that compounds of the type shown in figure 1.1 have 
anti-leukemic activity in vitro.[10] The in vivo application of such systems has not been 
tested in humans. However, a U.S patent has already been issued for arsenic dithiolates 
and other arsenic compounds as anti-cancer drugs.[11] 
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Figure 1.1. A structural representation of an arsenic dithiolate with anti-leukemic 
activity.[10] The most promising variant has R1 as H, R2 as NHCOCH3 and R3 as OH. 
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1.2 Fundamental Properties of Arsenic 
Heavier group 15 elements have been of interest since the beginning of recorded 
history. The history of arsenic is broad and colorful. Ranging from early uses as poisons 
and pigments to today’s applications in semiconductors, pesticides and main group 
chemistry, arsenic has found its place in many areas of chemistry. Within the series of 
arsenic, antimony and bismuth, arsenic has been the most studied. Arsenic is a grayish 
white metalloid. Arsenic has an atomic number of 33, an atomic mass of 74.92159 g/mol 
and only one stable isotope, 75As. Nitrogen, phosphorus, antimony and bismuth share 
their outer electron configurations with arsenic. Usually, arsenic is grouped together with 
the latter two elements due to similarities in chemistry, reactivity, size and similarities in 
coordination chemistry. 
1.3 Chemical and Physical Properties of Arsenic 
Arsenic has a number of allotropes. α-Arsenic is crystalline and stable in dry air, 
but in moist air the surface tarnishes until a grayish-black coating of amorphous β-arsenic 
forms. Yellow arsenic or γ-arsenic is made up of As4 molecules similar to white 
phosphorous. When elemental arsenic is heated in air, it sublimes and oxidizes to As4O6. 
Arsenic combines with metals to give arsenides and with fluorine to produce AsF5. Other 
halogens form compounds with the formula AsX3. Arsenic does not react easily with 
non-oxidizing acids, alkaline solutions or water. Dilute nitric acid combined with arsenic 
produces arsenous acid (H3AsO3), concentrated nitric acid yields arsenic acid (H3AsO4) 
and concentrated H2SO4 yields As4O6. Combination of elemental arsenic with NaOH 
produces hydrogen gas and sodium arsenite (Na3AsO3). One of the more marked 
differences between nitrogen, phosphorus and arsenic is the difficulty to oxidize arsenic 
6 
to the +5 oxidation state.[12] This is due to the underlying 3d orbitals, which more poorly 
shield the 4s2 electrons from the element’s increased nuclear charge thus making them 
harder to remove. Arsenic prefers, but is not limited to, three- and four-coordinate 
species. 
1.4 Geochemistry 
The abundance of arsenic in crustal rock is 1.8 ppm, which places it fifty-first in 
abundance compared to the other elements. Arsenic cannot be found in nature as a free 
element. It is a chalcophile, which means that it often occurs in association with sulfur, 
selenium and tellurium rather than as the oxide or silicate. However, the oxides are 
formed from the weathering of the igneous ores. Some common arsenic-containing 
minerals include arsenopyrite (FeAsS), realgar (As4S4), orpiment (As2S3), arsenolite 
(As4O6) and lollingite (FeAs2). Oxo-arsenic species and their chemistry in natural waters 
is an entire field of environmental speciation and remediation research. The aqueous 
speciation of arsenic in water is dependent on several factors, such as the presence of 
other dissolved species, Eh and pH. In water, arsenic exists as the neutral or anionic 
species HxAsO3x-3 under anoxic conditions and HxAsO4x-3 under oxic conditions. At 
neutral pH, the H3AsO3, H2AsO4-, and HAsO42- species predominate.[13-15]  
1.5 Sources of Arsenic in the Environment 
1.5.1 Natural 
There are more than 200 mineral species containing arsenic, the most common of 
which is arsenopyrite (FeAsS). Orpiment (As2S3), and realgar (As4S4) are the two 
primary arsenic minerals due to their availability and high arsenic content. Volcanoes are 
the most important natural source of arsenic in the environment in terms of the volume of 
7 
released arsenic. However, weathering of arsenic-containing minerals is significant and 
much more ubiquitous. West Bengal is a currently important example of an area affected 
by arsenic mineral weathering. The source of arsenic in that area has been ascribed to the 
reduction of arsenic-containing ferrous-coated sand grains and the oxidation of 
arsenopyrite in the aquifer.[16, 17] 
1.5.2 Anthropogenic 
Elemental arsenic is produced commercially by the reduction of arsenic trioxide 
(As2O3) with charcoal. As2O3 is produced as a by-product of metal smelting operations. 
Mining, smelting of non-ferrous metals, and burning of fossil fuels are the major 
industrial processes that contribute to anthropogenic arsenic contamination of air, water 
and soil.  
Historically, the use of arsenic-containing pesticides has left large tracts of 
agricultural land contaminated. The use of CCA (copper chromium arsenate) as a wood 
preservative is another source of contamination in the environment. Poultry operations 
use roxarsone (1) to control coccidial intestinal parasites to improve feed efficiency. The 
structure of roxarsone is shown in figure 1.2. Very little of the arsenic introduced in the 
feed is retained by the animal. Most of the arsenic is excreted in urine and feces. It has 
been estimated that this source produces 106 kilogram of arsenic per year.[18] Almost all 
of the poultry litter is used as an agricultural fertilizer. The roxarsone-containing fertilizer 
is spread over a field or tilled in. This is a common practice especially in grazing fields 
and hay fields. The use of arsenic contaminated poultry litter as a fertilizer is a significant 
source for arsenic contamination in agricultural surface waters. 
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1.6 Current EPA Policy and Methods for Drinking Water Treatment 
The U.S. Environmental Protection Agency (EPA) has accepted new limits on the 
content of arsenic in drinking water. The new maximum contaminant level is 0.010 mg/L 
which has gone into effect in 2006. Precipitation and co-precipitation are the most 
frequently used methods for treating arsenic-contaminated water. This usually involves 
adjustment of the pH to approximately 3 and addition of a chemical precipitant and 
oxidant to convert the arsenite (As(III)) to arsenate (As(V)). Arsenate is considerably less 
soluble than arsenite. The co-precipitants are usually ammonium sulfate, sulfide, ferric 
chloride and ferric sulfate.[19] Membrane filtration, adsorption treatment and ion exchange 
are also used. The membrane filtration techniques include micro-, ultra-, and nano-
filtration. Reverse osmosis is also used. In adsorption techniques, a fixed bed of 
adsorbent (most commonly activated alumina) adsorbs arsenic species in the water to its 
surface. Ion exchange relies on passing the water through a strong base anion exchange 
resin. As(III) is generally not removed by this method.[20]  
1.7 Historical Notes on Arsenic 
1.7.1 Cadet and Bunsen 
One of the first organometallic compounds synthesized is generally considered to 
be cacodyl (tetramethyldiarsine). It was the first example of metal-metal bonding and 
played a vital role in the development of organometallic chemistry. French pharmacist, 
Louis-Claude de Gassicourt (1731-1799) who was also known as Cadet de Gassicourt 
was the first to prepare this organoarsenic compound, although he did not realize he had 
done so. In his experiment, arsenic oxide was combined with potassium acetate and 
heated in a furnace yielding what he called a “liqueur fumante”.[21] Through the use of 
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Cadet’s fuming liquid, a large amount of research was performed by his contemporaries 
which increased the understanding of organo-arsenic compounds and in turn laid the 
groundwork for organometallic chemistry. The structures of tetramethyldiarsine (2) and 
cacodyl cyanide (3) are given in figure 1.2. 
R. W. Bunsen also investigated Cadet’s fuming liquid in the early to mid eighteen 
hundreds. Unlike Cadet, Bunsen had a pension for doing chemistry on the kilogram scale 
and so it was with the cacodyl compounds. Interestingly, Bunsen lived to the old age of 
88. This is impressive considering a rash of accidents in his lab with potentially toxic 
compounds such as cacodyl cyanide ((CH3)2AsCN). 
1.7.2  BAL, British Anti-Lewisite 
British Anti-Lewisite (BAL) was used in World War II as a treatment for poison 
gas exposure. BAL refers to 2,3-dimercaptopropanol (4). The poisons were based on 
organoarsenicals. Lewisite (5) is the best known poison from that era, although adamsite 
(dibenzo-1-chloro-1,4-arsenine) was also used. Lewisite’s chemical name is (2-
chloroethenyl)arsonous dichloride. The structure of Lewisite, the structure of BAL and 
the structure of the proposed product (6) are given in figure 1.3.  
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Figure 1.2. A structural representation of 3-nitro-4-hydroxyphenylarsonic acid 
(roxarsone) (1). Cadet’s cacodyl compound (tetramethyldiarsine) (2) and cacodyl cyanide 
(3). 
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Figure 1.3.   The 1930’s antidote British Anti-Lewisite (4), Lewisite (5), the hypothetical 
product of the two (6) and meso-2,3-dimercaptosuccinic acid (7). 
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Unfortunately, BAL has several undesirable side effects; it causes hypertension 
and tachycardia as well as headache, nausea, vomiting, salivation, and pain. It is 
generally given by intramuscular injection. The most common oral chelate in use today is 
meso-2,3-dimercaptosuccinic acid (7) as seen in figure 1.2. 
1.8 Industrial Uses 
Elemental arsenic is obtained on an industrial scale by smelting arsenopyrite 
(FeAsS) and loellingite (FeAs2) in an anoxic atmosphere between 650-700 °C.[12] Arsenic 
is used industrially as an additive to glass to reduce coloring, in semiconductors, in 
pigments such as Scheele’s Green (CuHAsO3), and in pesticides. Arsenic has been used 
to treat lumber as copper chromium arsenate (CCA) but CCA was phased out of use at 
the end of 2003. The addition of small quantities of As improve the properties of Pb/Sb 
storage batteries also automotive body solder consists of Pb (92%), Sb (5.0%), Sn (2.5%) 
and As (0.5%). 
1.8.1 Laser Windows and Hall Devices 
The III-V semiconductors, especially GaAs and InAs, are very important in the 
fabrication of LEDs, tunnel diodes, infrared emitters, laser windows and Hall-effect 
devices. AsH3 is also used as a dopant in semiconductors.   
1.8.2 Pesticides 
Arsenic-containing herbicides are readily available in most local hardware stores. 
Disodium methylarsonate (DSMA), monosodium methylarsonate (MSMA), monomethyl 
arsonic acid (MMA(V)) and arsenic acid are a few of the most common pesticides 
available. These compounds are commonly used to kill crabgrass and other unwanted 
grass types. There is only one commonly available arsenic-containing insecticide. 
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Arsenic trioxide (As2O3) is commonly used as an ant insecticide. Arsenic pentoxide 
(As2O5) is also used as an insecticide but is not very common. Arsenous acid and arsenic 
acid are common rodenticides.  
1.8.3 CCA Wood Treatment 
CCA (copper chromium arsenate) wood treatment consists of pressure treating 
wood which is usually to be placed in the ground. The arsenate leachate migrates shortly 
thereafter into the surrounding soil. CCA use has been discontinued in the U.S. as of 
2003. However, there are still wood products in the environment which were coated with 
CCA which pose a continued point source for arsenic leachate.    
1.9 Biological Chemistry of Arsenic 
Arsenic and antimony can interact with proteins as nonmetallic oxyanions or as 
soft metals through the formation of covalent bonds with the thiol groups on cysteines.[22, 
23] However, the actual molecular mechanism of inorganic arsenic toxicity is still not 
known.  
1.9.1 Oxidation-Reduction 
Arsenic has complex and varied oxidation-reduction chemistry. The two most 
common arsenic oxidation states are the +3 and + 5 state both in the environment and in 
vivo. Arsenic (0) and arsenic (-3) exist but are not environmentally relevant as 
contaminants. Arsenate and arsenite are the most common forms of arsenic found in the 
environment and are the primary inorganic contaminants in water. Therefore the means 
of methylation and the variations in toxicity of the two oxidation states compose an area 
of significant interest and research. 
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The metabolism of inorganic arsenic involves alternating steps of reduction from 
As(V) to As(III) and oxidative methylation of the As(III) species.[24-26] This scheme is 
known as the Challenger mechanism and can be seen in scheme 1.1. It has been shown 
that the oxidative damage induced by arsenic in the body occurs through dimethylated 
arsenic peroxide and not hydrogen peroxide or through a superoxide anion. Dimethylated 
arsenic species may play a role in arsenic carcinogesis by causing oxidative damage.[27] 
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Scheme 1.1. The Challenger Mechanism. A scheme for the metabolism of arsenic acid to 
the methylated metabolites. Steps (1), (3), (5), and (7) are reduction steps from As(V) to 
As(III). Steps (2), (4), and (6) are oxidative methylation steps.  
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1.9.2 Methylation 
The methylation of arsenic seems to be the method higher biological systems use 
to remove inorganic arsenic from the body. However, there is recent data suggesting that 
the methylation produces more toxic species such as monomethylarsonous acid 
(MMA(III)) and dimethylarsinous acid (DMA(III)).[28]  
Only two enzymes have been extensively studied in the arsenic methylation 
pathway, namely monomethylarsonic acid (MMA(V)) reductase and arsenic 
methyltransferase which leaves gaps in the mechanism of how the oxidative methylations 
and concurrent reductions occur. For example, it is still unknown which enzyme 
catalyzes the methylation of arsenic in the human body.[29]   
It has not been elucidated whether or not the formation of MMA(III) and 
DMA(III) in the liver of higher vertebrates is part of the detoxification of arsenic in the 
body, or if it is an intermediate product in a larger scheme. The commonly held pathway 
for the methylation of arsenate to DMA(III) has been called into question. Hayakawa et 
al. has proposed a pathway which places the MMA(V) and dimethylarsinic acid 
(DMA(V)) as the end products and not as intermediates in the reaction pathway.[30] 
Placement of DMA(V) and MMA(V) at the end of the detoxification route is an 
advantage due to the fact that these species are the primary species found in urine 
samples. It should be noted that the authors acknowledge issues with this proposed 
pathway as well. For example, human CYT 19, the protein suggested to do the 
methylation of the arsenic triglutathione by the Hayakawa et al. has only been 
synthesized using recombinant DNA technology. It has not been isolated and purified 
from human tissues. 
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Biomethylation seems to require the complexation of arsenic with thiol groups. 
This is probably due to the ability of the more electropositive sulfur over oxygen to make 
the lone pair on arsenic more basic, thus making the lone pair more reactive to the 
incoming methyl group. Also, it is easier to reduce arsenic (V) when bound to sulfur.[31] 
1.9.3 Dealkylation 
The biological methylation of arsenic has been studied extensively but the 
demethylation of arsenic has not received similar attention.[32] Frederick Challenger 
proposed the most widely accepted mechanism for arsenic methylation in 1945 and found 
that 2-chloro-ethanearsonic acid (ClCH2CH2As(O)(OH)2) is converted to trimethylarsine 
(As(CH3)3) by penicillium notatum. It was postulated that the arsenic-carbon between the 
ethylene carbon and arsenic is broken followed by methylation to form trimethylarsine. It 
has been reported that rats fed on arsenobetaine (Me3As+CH2COO-) excrete in urine, 
among other products, the dealkylated products trimethylarsine oxide (TMAO), 
dimethylarsenic acid (DMA(V)), monomethylarsenic acid (MMA(V)).[33] It has also been 
reported recently that mycobacterium neoaurum demethylates methylated arsenicals.[32] 
Several soil and sediment microorganisms can demethylate a wide range of 
organoarsenicals. The mechanism by which microorganisms demethylate methylated 
arsenicals is not known.[32] 
1.9.4 Arsenic Resistance 
There are arsenic resistant bacterium and microorganisms but the biological 
mechanism for the resistance in unknown.[34, 35]  There are several known arsenic operons 
in single-celled organisms. Their regulatory abilities for arsenic (III) and (V) are based on 
the formation of arsenic-cysteine bonds.[36] In fact, it is becoming clear that almost all 
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bacteria and archaea have arsenic resistant (ars) operons which confer some resistance to 
arsenate (V) and arsenite (III).[37]  However, most resistance systems function by energy-
dependent efflux of the respective ion.[38] Bacteria and fungi are known to produce 
volatile and toxic arsines but the physiological roles of arsenic methylation in 
microorganisms are unclear, and the biochemical basis is unknown.[39] 
1.10 Human Arsenic Toxicology  
Both organic and inorganic arsenic have an acute and long-term toxicity in 
humans. However the organic arsenic compounds are not considered to have a systemic 
toxicity.[40] As stated earlier, the mechanism(s) of the toxic action of inorganic arsenic are 
unknown.[41-43]  
Meat, fish, and poultry account for 80% of dietary arsenic intake. Organic arsenic 
compounds such as arsenobetaine (Me3As+CH2COO-), arsenocholine 
((CH3)3As+CH2CH2O-), tetramethylarsonium salts, arsenosugars and arsenic-containing 
lipids are mainly found in marine organisms. They are sometimes referred to as “fish 
arsenic”. Fish arsenic has a low toxicity in humans and is rapidly excreted in urine 
without much metabolic modification. That is not to say that there is no toxic effect. 
Arsenic (III) arsenosugars in particular will nick DNA plasmids. However, their toxicity 
is considerably lower than that of dimethylarsinous acid.[44] Organic arsenical species 
seem to be unaffected by human and higher vertebrate metabolism and as such are 
excreted largely unchanged which indicates that organic arsenicals are not a significant 
source of inorganic arsenic in vivo. This is especially true for trimethylarsenic with a 
mouse LC50 >20,000 ppm inhalation.[45]  There has been some interest as to whether the 
inorganic arsenic species are linked with birth defects especially neural tube defects. 
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However, it has been shown that in environmentally relevant scenarios, inorganic arsenic 
is unlikely to produce birth defects.[46]  
Recent research suggests that oxidative stress is the main cause of inorganic 
arsenic-induced cell death, where organoarsenical toxicity is thought to be in response to 
binding through thiol groups and inhibition of the activity of several enzymes.[47] Also, 
arsenite has been shown to disrupt kinase activity by binding to cysteines which are 
important to the activation of certain kinases.[48] It has also been shown that human 
lymphoblastoid cells have a high affinity for As(III) species.[42] A study by Rey et al. has 
proposed a molecular structure of As(III) bound by glutathione (GSH) (8).[49] The 
proposed structure is shown in figure 1.4. 
The speciation of arsenic in body fluids and a hint towards the longevity of 
arsenic in the body has been reported. After two years of ceased exposure to arsenic-
containing drinking water, detectable levels of arsenic were still found in human blood 
serum.[50] 
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Figure 1.4. Proposed molecular structure of the As(III)–GS complex (8). 
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Arsenite has been shown to inhibit pyruvate dehydrogenase activity by binding 
with vicinal thiols in pure porcine heart enzyme and human leukemia tissue extract. 
However, it is suggested that arsenite may be exerting its toxicity by promoting H2O2 
production in the mitochondria and thus inactivating enzymes by protein oxidation.[43] 
Arsenous acid and its trivalent methylated metabolites have been shown to react with 
metallothionein.[51]  
It has also been demonstrated that arsenite is able to distort polypeptide structure 
in order to achieve a trigonal pyramidal environment in solution. This, in turn, indicates 
that As(III) is able to distort biopolymers structurally. The structural affects of As(III) in 
vitro may play a significant role in the toxicity of the material.[52] 
Organoarsenicals can inhibit the pyruvate dehydrogenase system by reversibly 
binding to vicinal dithiols on dihydrolipoamide.[53] It has been established that 
organoarsenicals exert their toxicity by a different biological pathway than inorganic 
arsenic and as such, chelating therapy for acute organoarsenic intoxication is not 
necessary or helpful.[54] It has been recently shown that methylated trivalent arsenic 
species are genotoxic.[55, 56] It has also been determined that the comparable pentavalent 
arsenicals do not induce nicking or degradation of DNA. The trivalent arsenicals are 
considered to be direct acting. This means they do not require enzymes or other outside 
entities to exert their toxicity on DNA.  
Human fetal brain development can also be affected by arsenic exposure. In a 
recent study of human fetal brain explants, which were exposed to arsenic at 0.3 mg/L 
concentration, the brain tissue experienced degradation due to reactive oxygen species. It 
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was also found that the deleterious effects could be stemmed by addition of anti-
oxidants.[57] 
Arsenic analogues of phospholipids have been synthesized (arsinolipids) with 
some success but an extensive study of their biological activity has not been 
conducted.[58, 59]  
1.11 ADP-Arsenate 
A proposed but unsubstantiated mechanism for arsenic toxicity states that arsenate 
can irreversibly bind to adenosine-5-diphosphate (ADP) in place of the third phosphate in 
adenosine-5-triphosphate (ATP) and thus disrupt energy production in the cell. It has 
been seen that arsenate in high concentrations can substitute for phosphate in enzyme 
catalyzed reactions but it is postulated that the toxicity is not primarily due to the 
substitution.[60] The structure of ADP-arsenate (9) is shown in figure 1.5. 
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Figure 1.5. A structural representation of adenosine diphosphate arsenate (9). 
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Arsenolysis is the inhibition of the in vitro formation of adenosine-5-triphosphate 
by arsenate. ATP is the main high-energy species in vitro. On the substrate level, ATP 
forms during glycolysis in the presence of phosphate. Arsenate however cannot form 
ATP from the addition of ADP to arsenate. Adenosine-5-diphosphate–arsenate is also 
synthesized in the mitochondria from adenosine-5-diphosphate ADP and arsenate in the 
presence of succinate. ADP-arsenate formation at the substrate and mitochondrial level 
reduce ATP formation and thus inhibit many enzymatic reactions. More information on 
this particular system can be found in Hughes, 2002 and references therein.[61] 
1.12 Conclusion 
As can be seen from the previous sections, arsenic has a history as a component in 
toxic war agents, a cure for syphilis, a cancer treatment, a water contaminant and so on. 
The biological activity of arsenic in the body covers a broad spectrum from toxic to 
therapeutic agent. Based on the fact that arsenic compounds such as 
phenylarsenicdithiolates shown in figure 1.1 and similar organo-arsenic dithiolates are 
reported to have exhibited biological activity towards cancerous cells, it is suggested that 
cyclized arsenic thiolates can be synthesized with the appropriate characteristics as to be 
potentially useful as medicinal agents. This study also provides new structural and 
reaction information for the arsenic thiolate species in novel compounds which increases 
our understanding of the arsenic thiolate moiety. The targeted compounds would be those 
having an arsenic atom bound by two thiolate groups in a cyclic system, but with a 
potentially reactive halide group, still retain their biological activity. This hypothesis was 
to an extent confirmed in a recent patent where compounds such as S-dimethylarsino-
thiosuccinic acid, S-dimethylarsino-salicylic acid, and S-(dimethylarsino) glutathione 
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were patented for use as anti-leukemic drugs.[11] What is required is to demonstrate that 
these compounds can be prepared and that the dithiolate unit would remain intact under 
aqueous conditions. For medical purposes the compounds would be used by direct 
contact with the tumor.  
There is also a continued interest in the properties of arsenic and antimony 
containing thiolate compounds for both industrial and other biological uses as discussed 
in previous sections. The compounds reported herein will attempt to bring some light to 
these and other questions. In particular, these fully characterized compounds provide an 
understanding of the sulfur-arsenic interaction in living systems, determine how reactive 
the As–S and As–Cl linkages are under environmental and biological conditions, and 
provide a source of new reagents to examine in medical applications. There is also 
application for the reported compounds in filtration and remediation technology with 
some further modification. 
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Chapter 2 
 
Heterocyclic Halo-Arsenic Dithiolates and Trithiolates 
 
2.1 Overview 
In this chapter the synthesis and full characterization of five-, six- and seven-
membered arsenic thiolate compounds is presented. These compounds provide new 
structural data. The compounds are also examples of target compounds for biological 
testing on leukemic cells. The work was successful as several halo-arsenic dithiolates and 
arsenic trithiolates were synthesized and characterized. The primary reagents chosen for 
synthesis of the arsenic thiolates were arsenic trichloride, arsenic tribromide, arsenic 
trifluoride, and the respective thiols. Also, the arsenic trithiolates have been shown to be 
stable in aqueous solution. The aqueous stability of such compounds implies that the 
compounds if biologically active have the stability needed to be useful as medicinal 
agents. 
A pH study was conducted to test if the arsenic thiolate heterocycles were stable 
towards hydrolysis. It was demonstrated that the five-membered halo arsenic dithiolates 
are to some extent stable in pH 2 and 11 solutions and it was shown that the larger seven-
membered cycles are not as stable in solutions at the respective pH’s. This indicates that 
the 2-halo-arsenic dithiolate heterocycles are as such not suitable as a remediation 
technology. 
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2.2 Background  
There has been an interest in the 2-halo-1,3,2-dithiarsolanes and their derivatives 
since the use of Lewisite (Cl2AsCH=CHCl) 5 and similar toxic arsenic-containing 
warfare agents in World War II. Lewisite would be vaporized over the battle field and 
inhaled functioning similarly to common blistering agents like mustard gas. The first 
paper on the disposal of Lewisite was published in 1946 and described the synthesis of 
the non-toxic solid, 2-chloro-1,3,2-dithiarsolane, from arsenic trichloride and 1,2-ethane 
dithiol.[62] The motivation for the synthesis of such compounds was the need for a way to 
safely dispose of Lewisite and other arsenic chlorides in the late 1940s and 1950s. 2-
Chloro-1,3,2-dithiarsolane was synthesized according to the reaction shown in scheme 
2.1. The synthetic route involves the formation of two equivalents of hydrogen chloride 
gas, which can be used to monitor the progress of the reaction which goes to completion 
at room temperature. A comprehensive study on various synthetic routes available using 
1,2-bis-dithiarsolan-2-ylmercapto-ethane as a starting material appeared in 1967. The 
aforementioned compound was synthesized by the addition of 6 equivalents of ethane 
dithiol to one equivalent of arsenic trioxide (As4O6).[63, 64] Since that time, very little work 
in this area has been done. However, the synthesis of arsenic dithiolate cations as carbene 
analogues, an example of which is seen in figure 2.1 was successful in the late eighties 
and early nineties.[65-67] The arsenic dithiolate cations can be synthesized by halide 
abstraction with aluminum trichloride or gallium trichloride, thus forming the appropriate 
anion.  
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Scheme 2.1. Examples of synthetic routes to various di- and tri-thioarsenic compounds. 
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Figure 2.1. A bis(1,3-dithia-2-arsolidinium) cation (10). 
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The 2-halo-1,3,2-dithiarsenic compounds as well as the arsenic trithiolates were 
synthesized according to the synthetic pathways shown in scheme 2.1. The synthetic 
routes involved the formation of the respective equivalents of hydrogen chloride, or 
hydrogen bromide or the formation of an insoluble salt as the driving force behind the 
reactions. The reactions can be monitored by observing gas evolution or salt formation 
and go to completion at room temperature.  
One of the first single-crystal X-ray structure determinations of an arsenic 
dithiolate was conducted in 1972 by Cruse and James.[68] A molecular structure of the 
product of arsenite and 1,4-dithiothreitol is shown in figure 2.2. 8-Oxa-2,7-dithia-1-arsa-
bicyclo(1,3,2)-octan-4-ol (11) was the first structurally characterized example of an 
arsenic dithiolate ring. 
Complexes of British Anti-Lewisite and phenyldichloroarsenic and a complex of 
dimercaptosuccinic acid and phenyldichloroarsenic have been synthesized. They were 
formed by addition of the respective dithiol to phenyldichloroarsenic in acetone. The 
BAL adducts seem to be more stable in comparison to the dimercaptosuccinic acid 
derivatives due to exchange seen in the NMR spectra with trace water.[69]  
With the previous work conducted as a stepping stone and an interest in the 
medicinal efficacy of arsenic dithiolates, the author set out to synthesize, characterize and 
understand the aspects of the arsenic dithiolate and trithiolate moiety. A list of the 
compounds synthesized for this chapter are given in figure 2.3.  
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Figure 2.2. The molecular structure of 8-oxa-2,7-dithia-1-arsa-bicyclo(1,3,2)-octan-4-ol 
(11).   
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Figure 2.3. A structural representation of the arsenic dithiolates (12-22). 
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2.3 Experimental Section 
2.3.1 General  
Caution. Arsenic compounds are toxic and should be handled with care. 
AsCl3 was purchased from Alfa Aesar. AsF3 was purchased from SynQuest Labs. Both 
AsCl3 and AsF3 are highly toxic and carcinogenic and must be handled and disposed 
of as hazardous materials. The dithiols obtained from Aldrich were used as delivered 
without further purification. All manipulations were carried out using standard 
inert atmosphere techniques under a nitrogen atmosphere. 
NMR spectra were obtained at room temperature in CDCl3 on Varian Gemini 200 
or Varian Innova 400 NMR spectrometers. Chemical shifts are reported in ppm, relative 
to tetramethylsilane. 19F spectra are referenced to α,α,α-trifluorotoluene. FT-IR spectra 
were recorded as KBr pellets on a Varian Spec 9800. GC-MS data were obtained on 
either an Agilent Technologies 6890N GC system with an Agilent Technologies 7683B 
injector and an Agilent Technologies 5973N mass selective detector or on a Varian 
CP3800 GC with a Varian Saturn 2200 Ion Trap MS and CTC Analytics CombiPAL 
autosampler. Melting points were obtained on a Mel-Temp melting point apparatus. 
X-ray diffraction data were collected at 90 K on a Nonius Kappa CCD diffractometer unit 
using Mo Kα radiation from colorless regular shaped crystals mounted in Paratone-N oil 
on glass fibers. Initial cell parameters were obtained using DENZO from 1° frames and 
were refined by a least-square scheme using all data-collection frames 
(SCALEPACK).[70] The structures were solved by direct methods (SHELXL-97) and 
completed by difference Fourier methods (SHELXL-97).[71] Refinement was performed 
against F2 by weighted full-matrix least-square. Hydrogen atoms were placed at 
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calculated positions using suitable riding models with isotropic displacement parameters 
derived from their carrier atoms. Non-hydrogen atoms were refined with anisotropic 
displacement parameters. Atomic scattering factors were taken from the International 
Tables for Crystallography volume C.[72] Details of crystal data, data collection, and 
structure refinement are listed in the appendix. 
2-Chloro-1,3,2-dithiarsolane (12)  
1,2-Dithioethane (2.39 g, 25.4 mmol) in 50 mL CCl4 was added drop-wise to arsenic 
trichloride (5.03 g, 28.0 mmol) in 50 mL CCl4 at room temperature. The reaction was 
stirred for an hour and then moved to a freezer at -20 oC where 5.13 g of a crystalline 
solid formed overnight. The crystals were kept at -20 oC and the solution filtered off to 
obtain a yield of 97.9%. Mp: 38.5–39.0 oC. 1H NMR (CDCl3): δ 3.77 (m, 4H). 13C NMR 
(CDCl3): δ 44.63 (s). IR (ν, cm-1, KBr): 3448 (m, br), 2951 (m), 2910 (m), 1722 (w), 
1642 (w), 1409 (s), 1384 (m), 1281 (m), 1231 (w), 1144 (w), 1106 (w), 992 (w), 930 (m), 
832 (s), 669 (w), 644 (w), 599 (w), 450 (w). Mass spectra (GC–MS): 202 
(AsCl(SCH2CH2S))+, 167 (As(SCH2CH2S))+. 
2-Bromo-1,3,2-dithiarsolane (13)  
1,2-Dithioethane (0.59 g, 6.28 mmol) in 30 mL CCl4 was added drop-wise to arsenic 
tribromide (2.22 g, 7.06 mmol) in 30 mL CCl4 at room temperature. Gas evolved upon 
addition. The reaction was stirred for twelve hours under N2 with intermittently venting 
to the atmosphere and then moved to a freezer at -20 oC where 0.42 g of a crystalline 
solid formed overnight. The crystals were kept at -20 oC and the solution filtered off to 
obtain a yield of 27.1%. The crystals were not of sufficient quality and so were 
recrystallized in CDCl3/CHCl3 to obtain high quality crystals. Mp: 48-49 oC. 1H NMR 
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(CDCl3, ppm): δ 5.00 (-CH2-, s, 4H). 13C NMR (CDCl3, ppm): δ 45.22 (-CH2-). IR (ν, 
cm-1, KBr): 2965.95 (m), 2915.42 (m), 1629.40 (w), 1409.73 (s), 1384.17 (w), 1280.86 
(m), 1232.31 (m), 1145.53 (w), 1111.12 (w), 994.38 (m), 930.93 (s), 834.88 (s), 661.47 
(m), 649.92 (s) 452.49 (m). Mass spectra (GC-MS): 248 (BrAs(SCH2CH2))+, 167 
(As(SCH2CH2))+, 107 (AsS)+. 
2-Iodo-1,3,2-dithiarsolane (14) 
Sodium iodide (0.75 g, 5.00 mmol) was dissolved in 20 mL of acetone and added drop-
wise to 2-chloro-1,3,2-dithiarsolane (1.01 g, 5.00 mmol) dissolved in 20 mL acetone at 
room temperature. A white precipitate formed and the solution turned red. The solvent 
was removed under vacuum to isolate an orange solid. This solid was recrystallized from 
CCl4/CHCl3 to yield 1.14 g of crystalline solid (78.0%). Mp: 74.0-74.5 oC. 1H NMR 
(CDCl3): δ 3.81 (d, 4H). 13C NMR (CDCl3): δ 46.07 (s). IR (ν, cm-1, KBr): 3447 (m, br), 
2960 (w), 2902 (w), 1628 (m), 1403 (m), 1277 (w), 1106 (w), 929 (w, sh), 827 (m), 664 
(m), 445 (w). Mass spectra (GC-MS): 294 (AsI(SCH2CH2S))+, 167 (As(SCH2CH2S))+. 
2-Chloro-1,3,2-dithiarsenane (15) 
1,3-Dithiopropane (2.75 g, 25.5 mmol) was dissolved in 25 mL of CCl4 and added drop-
wise to a solution of arsenic trichloride (5.04 g, 27.1 mmol) in 25 mL CCl4 at room 
temperature. The reaction was stirred for an hour and the solution cooled to -20 oC and 
kept at that temperature for 24 h at which point a white crystalline precipitate formed. 
The solution was filtered and the resulting solid dried completely, yielding 4.96 g of a 
crystalline solid in 90.0% yield. Mp: 40.5-41.0 oC. 1H NMR (CDCl3): δ 3.50 (m, 2H), δ 
3.06 (m, 2H), δ 2.27 (m, 2H). 13C NMR (CDCl3): δ 26.587 (s), δ 25.797 (s). IR (ν, cm-1, 
KBr): 3448 (m, br), 2904 (m), 2820 (w), 2360 (w), 1635 (w), 1416 (s), 1338 (w), 1296 
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(m), 1269 (m), 1245 (m), 1179 (w), 1115 (w), 995 (w), 899 (w), 855 (w), 803 (w), 739 
(w), 618 (m), 411 (w). Mass spectra (GC-MS): 216 (AsCl(SCH2CH2CH2S))+, 181 
(As(SCH2CH2CH2S))+. 
2-Bromo-1,3,2-dithiarsenane (16) 
1,3-Dithiopropane (0.71 g, 6.57 mmol) was dissolved in 30 mL of CCl4 and added drop-
wise to a solution of arsenic tribromide (2.27 g, 7.21 mmol) in 40 mL CCl4 at room 
temperature. Upon addition, gas evolved from the solution. The reaction was stirred for 
twelve hours under N2 with intermittently venting to the atmosphere. Approximately 15 
mL of solvent was removed via evaporation. The solution was then cooled to -20 oC and 
kept at that temperature for one week after which approximately 30 mL of solvent was 
removed under vacuum and 5 mL of CH2Cl2 and 5 mL of acetone were added and the 
solution was cooled to -20  oC at which point a white crystalline solid formed. The 
solution was filtered and the resultant solid dried completely, yielding 1.53 g of a 
crystalline solid in 89.0% yield. Mp: 30-31 oC. 1H NMR (CDCl3): δ 3.29 (-CH2-, m, 2H), 
δ 3.19 (-CH2-, m, 2H), δ 2.24 (-CH2-, m, 2H). 13C NMR (CDCl3): δ 27.15 (-CH2-), δ 
26.66 (-CH2-). IR (ν, cm-1, KBr): 2906.11 (s), 2817.47 (m), 1418.10 (s), 1337.91 (w), 
1297.27 (m), 1271.23 (s), 1239.73 (m), 1179.42 (m), 1142.29 (w), 1115.79 (w), 996.77 
(w), 899.26 (m), 855.92 (s)  804.64 (m), 738.11 (w), 674.76 (w), 621.01 (m), 491.69 (w), 
454.06 (w). Mass spectra (GC-MS): 262/260 (BrAs(SCH2CH2CH2S))+, 181 
(As(SCH2CH2CH2S))+, 107 (AsS)+. 
2-Iodo-1,3,2-dithiarsenane (17) 
Sodium iodide (0.75 g, 5.00 mmol) in 10 mL acetone was added to 2-chloro-1,3,2-
dithiarsenane (1.08 g, 4.99 mmol) dissolved in 20 mL of acetone at room temperature. 
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Both solutions were clear before addition. Upon addition, the solution took on a bright 
orange tint and a white precipitate formed. The white precipitate was filtered out and part 
of the solvent was removed from the solution under vacuum. The solution was then 
allowed to crystallize and 0.24 g of dark red orange crystals formed at -20 oC in a 15.6% 
yield. Mp: 45-46 oC. 1H NMR (CDCl3, ppm): δ 3.24 (t, 4H), δ 2.29 (p, 2H). 13C NMR 
(CDCl3, ppm): δ 31.14 (s), δ 26.95(s). IR (ν, cm-1, KBr): 3448 (m, br), 2896 (m), 2832 
(m), 2364 (w), 1627 (m), 1412 (s), 1364 (w), 1293 (w), 1265 (m), 1179 (w), 892 (w), 851 
(w), 802 (w), 775 (w), 616 (w). Mass spectra (GC-MS): 308 (AsI(SCH2CH2CH2S))+, 181 
(As(SCH2CH2CH2S))+. 
3-Chloro-4H,7H-5,6-benz-1,3,2-dithiarsepine (18) 
1,2-Bis-mercaptomethylbenzene (1.00 g, 5.87 mmol) was dissolved in 20 mL of CCl4 and 
added drop-wise to arsenic trichloride (1.20 g, 6.62 mmol) in 20 mL CCl4 at room 
temperature. The reaction was stirred overnight and cooled to -20 oC and kept at that 
temperature for a week. Clear star-like crystals formed in the solution. The solvent was 
then removed yielding 1.57 g of a crystalline solid in a yield of 96.2%. Mp: 117-119 oC. 
1H NMR (CDCl3, ppm): δ 7.17 (phenyl, m, 4H), δ 5.11 (CH2, d, 2H), δ 3.934 (CH2, d, 
2H). 13C NMR (CDCl3, ppm): δ 139.31, δ 130.51, δ 129.60 (-phenyl-), δ 33.20 (-CH2-). 
IR (ν, cm-1, KBr): 3448 (wb), 3055 (w), 3026 (w), 2964 (w), 2933 (w), 1643 (w), 1493 
(s), 1440 (s), 1416 (w), 1385 (w), 1301 (w), 1236 (m), 1211 (w), 1185 (m), 1156 (w), 
1073 (w), 949 (w), 860 (w), 828 (w), 766 (vs), 762 (s), 666 (s), 589 (m), 499 (m). 
Mass spectra (GC-MS): 243 (As(SCH2)2(C6H4))+, 168 ((SCH2)2(C6H4))+, 104 
((CH2)2(C6H4))+. 
2-Chloro-benzo-1,3,2-dithiarsole (19)  
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1,2-Benzenedithiol (0.50 g, 3.5 mmol) in 20 mL CCl4 was added drop-wise to arsenic 
trichloride (0.70 g, 3.9 mmol) in 20 mL CCl4 at room temperature. The reaction was 
stirred for an hour and then moved to a freezer at -20 oC where crystals formed overnight. 
The crystals were kept at -20 oC. The solution was filtered and 0.55 g of a crystalline 
material was obtained with a yield of 62.9%. Mp: 87.5-88.0 oC. 1H NMR(CDCl3, ppm, 
400 MHz): δ 7.59 (benzene, m, 2H), δ 7.23 (benzene, m, 2H). 13C NMR (CDCl3, ppm, 
100 MHz): δ 139.49 (=CS-), δ 127.11 (=CH-), δ 126.37 (=CH-). IR(ν, cm-1, KBr): 3438 
(wb), 3057 (m), 1900 (w), 1630 (m), 1556 (w), 1445 (s), 1422 (s),1384 (m),1274 (w), 
1249 (w), 1135 (w), 1106 (m), 934 (m), 847 (w), 741 (s), 660 (m), 470 (m), 429 (m). 
Mass spectra (GC-MS): 215 (As(SC6H4S)) +, 108 (SC6H4)+. 
1,2-Bis-dithiarsolan-2-ylmercapto-ethane (20) 
2-Chloro-1,3,2-dithiarsolane (1.01 g, 5.00 mmol) was dissolved in 20 mL of THF and an 
aqueous solution of Na2CO3 (1.00 g, 9.43 mmol, in 60 mL H2O) was added to form a 
white precipitate. The solution was stirred for 5 minutes and then filtered to isolate 0.379 
g of a white precipitate in a yield of 53.4%. The precipitate was dissolved in a 
50/50 solution of CHCl3/CH3OH and slowly evaporated to obtain X-ray quality crystals. 
Mp: 81.5-82.0 oC. 1H NMR (CDCl3):  δ 3.507 (m, 8H), δ 3.106 (s, 4H). 13C NMR 
(CDCl3): δ 42.722 (s), δ 35.890 (s). IR (ν, cm-1, KBr): 3449 (b), 2947 (w), 2906 (s), 1594 
(m), 1409 (s), 1275 (s), 1195 (s), 1110 (w), 991 (w), 929 (w), 831 (s), 720 (w), 679 
(m), 645 (w), 451 (w). Mass spectra (GC-MS): 167 (AsSCH2CH2S)+. 
tris-(Pentafluorophenylthio)-arsen (21) 
Arsenic trifluoride (1.00 ml, 20.02 mmol) was dissolved in 5 mL of CCl4 and 
pentafluorothiophenol (5.40 mL, 40.50 mmol) was dissolved in 20 mL of CCl4. Upon 
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slow addition of the two solutions, a white precipitate formed. The reaction was left 
stirring for 24 h under a N2 atmosphere. The solvent was then removed and the  
precipitate was dissolved in a mixture of CH2Cl2, toluene, acetonitrile and 
trifluorotoluene in a 1:1:3:3 ratio. The solvent mixture was evaporated slowly to produce 
9.068 g of X-ray quality crystals in a yield of 99.96%. Mp: 76-77 oC. 19F NMR (CDCl3, 
ppm): δ -135.29 (m)(C-F meta), δ -153.35 (m)(C-F para), δ -164.27 (m)(C-F ortho). IR(ν, 
cm-1, KBr): 1637 (m), 1488 (s), 1401 (w), 1377 (w), 1291 (w), 1093 (vs), 1019 (w), 980 
(vs), 859 (vs), 723 (w), 634 (w), 417 (w). Mass spectra (GC-MS): 473 (As(SC6F5)2)+, 274 
(As(SC6F5))+. 
Bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)-benzenesulfide) (22) 
Arsenic trifluoride (1.02 g, 7.74 mmol) was added drop-wise to 1,2-benzenedithiol (1.00 
g, 7.03 mmol) neat at room temperature. 10 mL of CCl4 and 10 mL of CH2Cl2 was added 
and the reaction was stirred overnight and cooled to -20 oC and kept for a week. Yellow 
block-like crystals formed in the solution. The solvent was then removed yielding 0.45g 
of a crystalline solid with a yield of 36.0%. Mp: 158-160 oC. 1H NMR (CDCl3, ppm): δ 
7.60 (phenyl, q, 2H), δ 7.47 (phenyl, q, 2H), δ 7.45 (phenyl, q, 4H), δ 7.22 (phenyl, q, 
2H) δ 7.11 (phenyl, q, 2H), δ 7.08 (phenyl, q, 4H). 13C NMR (CDCl3, ppm): δ 143.75 (-
phenyl-), δ 139.99 (-phenyl-), δ 135.57 (-phenyl-), δ 128.92 (-phenyl-), δ 127.00 (-
phenyl-), δ 1125.81 (-phenyl-). IR (ν, cm-1, KBr): 3430.61 (vwb), 3048.05 (m), 1627.75 
(mb), 1444.02 (s), 1436.66 (s), 1418.31 (w), 1384.42 (m), 1271.38 (w), 1246.87 (w), 
1105.89 (m), 1032.19 (m), 800.57 (s), 737.29 (vs), 658.78 (w), 479.23 (w), 424.50 (w). 
Mass spectra (GC-MS): 281 (SC6H4SSC6H4S)+, 248 (SC6H4SSC6H4)+, 215 (AsSC6H4S)+, 
171 (AsS3)+, 139 (AsS2)+ ,108 (SC6H4)+, 107 (AsS)+. 
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2.4 Results 
2.4.1 Spectroscopy 
The 1H NMR spectrum of 12 shows a multiplet (3.77 ppm) for the ethylene 
protons and the 13C NMR spectrum shows a singlet (44.63 ppm) for the ethylene carbons. 
It can be concluded that there is only one magnetic environment for the ethylene carbons. 
The IR spectrum for compound 12 is strikingly similar to compounds 13-19. The C–S 
stretches at 669 and 644 cm-1 and As–S stretch at 450 cm-1 indicate the presence of a 
ring.[73, 74] 
The IR and Raman spectra of 13 have been reported previously by Gates et al.[74] 
The characterizational data published previously for 13 matches well with the data 
obtained. The 1H NMR spectra of 13 shows only one signal at 5.00 ppm which has been 
assigned to the methylene protons. This indicates that there is only one magnetic 
environment for the ethylene protons. The 13C NMR also shows one signal which is at 
45.22 ppm which has been assigned to the ethylene carbons. The IR spectrum shows the 
characteristic C–S stretches at 661 cm-1 and 650 cm-1 and the As–S stretch at 452 cm-1. 
The 1H NMR spectrum of 14 shows a doublet (3.81 ppm) for the ethylene protons 
and the 13C NMR spectrum shows a singlet (46.07 ppm) for the ethylene carbons. Just as 
in 12, it can be concluded that there is only one magnetic environment for the ethylene 
carbons. Some of the spectroscopic data reported here does not match the published data 
available for 14.[73, 75] In particular, the 1H NMR signal at 3.81 ppm differs considerably 
from the published value of 3.00 ppm. This could be due to solvent effects (CDCl3 vsrsus 
C6D6). Also, the IR spectrum shows the characteristic C–S and As–S stretches at 664 and 
445 cm-1, respectively. 
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In compound 15, there are three multiplets (3.50, 3.06 and 2.27 ppm) for the 
hydrogens on the propylene carbons, which are similar to the previously reported values 
of 3.43, 2.76, and 1.85 ppm. The differences can be attributed to the use of different 
NMR solvents (CDCl3 versus C6D6).[76] The fact that there are three 1H NMR signals is 
due to the axial and equatorial signals from the protons on C1 and C(1A) and a multiplet 
due to the protons on C2. Pyramidal inversion is possible at the arsenic but with a high 
energetic barrier (25-42 kcal/mol), the inversion is slow.[77, 78] This explains the three 
distinct multiplets seen in the 1H NMR. The IR spectrum shows the C–S stretch (618 cm-
1) and the As–S stretch (411 cm-1). 
Apparently 16 is a new compound and has not been previously characterized by 
structural or spectroscopic means. The 1H NMR data obtained for 16 shows three signals. 
They have been assigned as 3.29 ppm and 3.19 ppm belonging to the two proton 
environments seen on C1 and C3. The axial and equatorial protons experience different 
environments. The protons on C2 at 2.24 ppm are split to a lesser degree due to a smaller 
coupling constant which results in one multiplet for the protons on C2. The 13C NMR 
spectrum yields two signals at 27.15 ppm and 26.66 ppm respectively which coincide 
with the two different carbon environments. The infrared spectrum shows the As–S bond 
at 492 and 454 cm-1 and the C–S bonds are seen at 675 and 621 cm-1. 
The 1H NMR of 17 shows a triplet and a pentet (3.24, 2.28 ppm) for the 
hydrogens on the propylene backbone. The 13C NMR shows two singlets (31.14, 26.95 
ppm) which correspond to the ortho and para positions, respectively. The IR spectrum 
shows the C–S stretch (616 cm-1) but the As–S stretch is not observed. This is most likely 
due to the band falling very close to the edge of the range of the instrument (400 cm-1). 
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The spectroscopic data are consistent with what is expected based on the IR, 1H and 13C 
NMR of the chloro analogue.  
The spectroscopic data obtained for compound 18 relates well to the published 
information available.[79] The 1H NMR show the phenyl hydrogens (7.17 ppm), and 
methylene hydrogens (5.11, 3.93 ppm). The methylene hydrogens are in different 
magnetic environments and are split. This is due to the anomeric effect which states that 
the heteroatomic substituent prefers an axial alignment in the heterocycle. Two of the 
hydrogens on the methyl groups are closer to the chlorine and are in different 
environments. The 13C NMR shows the carbon in the phenyl ring (139.31, 130.51, 129.60 
ppm) and the methyl carbons (33.20 ppm). The strong bands at 766 cm-1 and 661 cm-1 in 
the IR spectrum indicate an anti-symmetric stretch and a symmetric stretch between 
carbon and sulfur, respectively. This is unusual because these bands are usually weak and 
the anti-symmetric band is rarely observed. The As–S stretch is shifted higher than seen 
in the other compounds at 500 cm-1.     
Compound 19 has two multiplets in the 1H NMR (7.59 and 7.23 ppm) which 
correspond to the benzene protons. The 13C NMR spectrum yields three signals (139.49, 
127.11, and 126.37 ppm) which correspond well with the benzene carbons. The IR 
spectrum yields the characteristic peaks expected for an arsenic dithiolate. The C–S 
stretch can be seen at 660 cm-1 and As–S stretches are seen at 470 and 429 cm-1. A 
similar compound, 2-chloro-5-methyl-1,3,2-benzodithiarsole, was reported previously 
and uses the toluene 3,4-dithiol moiety to bind to the arsenic center.[80] The reported 
compound differs from compound 19 by having a methyl group in the  1-position in 
reference to the 3,4-dithiol moiety. 
42 
The 1H NMR spectrum of 20 shows a multiplet (3.51 ppm), which arises from the 
ethylene hydrogens in the ring, and a singlet (3.11 ppm), which is due to the bridging 
ethylene hydrogens. There are two signals in the 13C NMR spectrum, a singlet due to 
ethylene carbons in the ring (42.72 ppm) and a singlet due to the bridging ethylene 
carbons (35.89 ppm). The IR spectrum shows three bands which represent the A// ring C–
S stretch (679 cm-1), A/ ring C–S stretch (645 cm-1) and A/ As–S ring deformation (451 
cm-1). These are similar to the published values.[1]  
The 19F NMR of 21 shows the fluorines in the meta, para, and ortho positions on 
the phenyl rings (-135.29, -153.35, -164.27 ppm), respectively. The IR spectrum obtained 
indicates an aromatic C–C stretch (1489 cm-1), C–F stretches (1094 cm-1, 980 cm-1), a C–
S stretch (860, 635 cm-1), and an As–S stretch (417 cm-1). 
Compound 22 has six signals corresponding to the phenyl protons in the 1H NMR 
and six signals in the 13C NMR which is consistent within the molecule.  Nine magnetic 
environments exist for the carbon atoms however the carbons with no protons are not 
seen due to a lack of the Nuclear Overhauser Effect (NOE). Compound 22 displays the 
characteristic IR bands seen in organo-arsenic thiolates. The band at 659 cm-1 is 
indicative of C–S bonds and the peaks at 479 and 425 cm-1 are  in the correct range for 
As–S bonds in the ring.[73, 74] However, the As–S stretches are usually weak. 
2.4.2 Structure 
Compound 12 has been crystallized in both the P21/c and P212121 space groups. 
The X-ray structure of 12 has been previously reported.[66, 81]  However, the crystals were 
crystallized in the monoclinic space group P21/c, whereas 12 was also crystallized in the 
orthorhombic space group P212121. This was achieved by changing the conditions of 
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crystallization. Compound 12 was dissolved in CCl4 and a molar equivalent of benzyl 
alcohol added and then recrystallized in the orthorhombic space group. The alcohol 
clearly influenced the crystallization but does not appear in the structure. In the 
orthorhombic P21/c space group the variance in bond lengths between As and S on the 
same molecule is approximately 0.0314 Å whereas in the P212121 space group the As–S 
bonds have a variance of approximately 0.0188 Å. These values lie within or are 
extremely close the value of 0.02 Å, which is the limit for experimental error in the single 
crystal X-ray structure determination.  
Crystal dimorphism as seen in 12 is of great theoretical and practical interest. 
Different morphs of the same material can have a range of physical, chemical and 
biological properties.  
Compound 13 has been extensively characterized by spectroscopic means as well 
as by electron diffraction. However, a single crystal X-ray structure determination of this 
molecule has not been reported until now. An electron diffraction study was conducted 
on 13 by Zaripov et al.[82] Compound 13 crystallizes in the orthorhombic space group 
P212121. The bond lengths and angles are very similar to the previously reported halo-
1,3,2-dithiarsolanes.[66, 81, 83] Thus, varying the terminal halide from Cl to Br to I, seems 
to have little effect on the bond angles and distances within the five-membered 
heterocyclic ring. Compound 13 exhibits strong intermolecular interaction between the 
As1 and the S2 of its nearest neighbor. The arsenic atom in each molecule takes on 
pseudo four-coordinate geometry with a sulfur atom within 0.2 Å of the sum of the van 
der Waals radii. 
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Compound 14 contains two molecules in its asymmetric unit and crystallizes in 
the monoclinic space group Cc. The bond lengths and angles are very similar to 12 as 
seen in Table 3. Thus, varying the terminal halide seems to have little effect on the bond 
angles and distances in the halo-dithiarsolanes. However, the distance between I(1)B to 
S(2)A is 3.745 Å in the packing diagram and as such is within the sum of the Van der 
Waals radii for I and S at 3.78 Å. The slightly shortened distances are likely due to the 
packing within the unit cell. However, the As(1A)–I(1A) distance is 2.65 Å which when 
compared to the sum of the covalent radii (2.54 Å) is longer, indicating a more ionic 
bond. 
The halo-1,3,2-dithiarsolanes crystallize in different space groups. However, 
varying the terminal halide from Cl to Br to I, seems to have little effect on the bond 
angles and distances within the heterocycle indicating a very defined heterocyclic 
structure which in unaltered by variation in the terminal group. 
Compound 15 crystallizes in the orthorhombic space group Pnma. The S–As–S 
bond angle is 102° which is considerably wider than in the five-membered rings. 
However, this has little effect on the As–S bond length (2.22 Å). Thus, there are no 
strong distortions in either the five- or six-membered ring compounds containing As–Cl 
bonds. In the unit cell, the intermolecular arsenic hydrogen distances are around 3.02 Å, 
while the chlorine hydrogen distances are around 2.90 Å. Both of these values are within 
the sum of the van der Waals radii (3.05 and 2.95 Å) of the respective atoms. 
Compound 16 crystallizes in the monoclinic space group P21/c. The structural 
data obtained for 16, when compared to the structural data previously obtained for 2-
chloro- and 2-iodo analogues 15 and 17, shows almost identical bond lengths between all 
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the atoms except the As–X (X=Cl, Br, I) naturally. The bond angle S–As–S has a 
variance within a 1.6° between the 2-chloro-, 2-bromo- and 2-iodo-1,3,2-dithiarsenane 
analogues. Therefore, it can be said that the identity of the halide has very little effect on 
the six-membered heterocyclic ring.  
Compound 17 crystallizes in the monoclinic space group P21/n. The iodine atom 
seems to have little effect on the bond angles and bond distances of the molecule versus 
the chlorine analogue of course with the exception of the As–I bond length and angles 
including As–I. In the solid state, the iodine breaks the symmetry of the molecule 
whereas the chlorine analogue maintains a higher level of symmetry with a σv (vertical 
mirror plane) passing through the middle of the molecule and containing the halide. This 
could be due to larger displacement of the iodine atom and a slight shift of the iodine 
away from the symmetry axis. The As–S bonds are slightly elongated and the angle made 
by S–As–X is widened by 2.4° more in the iodo complex but the S–As–S bond angle is 
slightly smaller in the iodo complex, 102.20° versus 101.42° in the chloro analogue and 
100.60° for the bromo analogue. 
Compound 18 crystallizes in the orthorhombic space group Pnma. The chosen 
route to obtain a seven membered arsenic dithiolate ring involves ‘‘locking’’ the 
backbone forming a 1,3,2-dithiarsepine heterocycle. The S–As–S bond angle in 18 
demonstrates considerable strain from the normal trigonal pyramidal geometry by having 
the largest angle seen thus far at 105°. There are no π-stacking effects observed in the 
structure of 18. The arsenic and backbone carbons are approximately 3.55 Å apart which 
coupled with the molecular geometry around As causes the lone pair of the arsenic to be 
centered directly over the phenyl ring. 
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A structural representation of compound 19 is shown in figure 2.9. The structure 
is similar to that of compound 12 in terms of bond lengths and bond angles around 
arsenic. In the structure of the toluene analogue (ClAs(SC7H7S)) published by Wandiga 
et al., the actual S–As–S ring structure also resembles what is found in 12.[80] This lends 
credence to the values obtained here. The single crystal X-ray structure of compound 19 
was not able to be completely refined due to the unit cell containing 17 distinct 
molecules. This is not a realistic representation of the packing within the crystal. 
However, the determined values for the bond lengths and bond angles are valid. The 
values used for comparison of bond length are the average of all seventeen molecules. 
Whereas, the values used for the bond angles were taken from molecule J in the 
seventeen molecule asymmetric unit. The values were taken from one molecule however 
all of the molecules in the structure had very small bond angle variations. If the 
asymmetric unit is correct, it would make compound 19 crystallographically unique. The 
unit cell contains the number of molecules needed to complete a repeating unit in three 
dimensions. Within that unit cell, there can be a number of asymmetric units. Compound 
19 would have an odd number of molecules in its asymmetric unit and have a high 
number of molecules which is a rarity. 
Compound 20 crystallizes in the orthorhombic space group P212121. The As–S 
bond lengths range from 2.23-2.28 Å and the S–C bond lengths are around 1.81-1.84 Å. 
These are typical As–S and S–C bond lengths. However, there is a narrowing of the bond 
angle between S1–As1–S2 and S5–As2–S6 in compound 20 and the angle made with the 
sulfur located on the linkage. The constriction is approximately 6° with a range from 93° 
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to 102°. Consequently, the five-membered rings do not deviate significantly from a 
distorted trigonal pyramidal structure at the arsenic center.  
Compound 21 crystallizes in the orthorhombic space group Fdd2 and has As–S 
bond distances of 2.26–2.27 Å which is in the expected range. However, the angles 
around the arsenic center are somewhat unexpected. Two of the angles lie in the region of 
98.3°– 98.5° whereas one is significantly more acute at 87.8°. It is possible that the bond 
angle constriction is due to steric interactions between the pentafluorothiophenyl groups. 
The bond lengths between the arsenic center and the different sulfurs vary from one 
another by only 0.06 Å. 
Compound 22 crystallizes in the C2/c space group. The arsenic sulfur distances 
are almost identical between compounds 18 and 22. The sulfur-arsenic-sulfur bond angle 
is considerably larger in 18 versus 22 at 105.06° vs. 91.86°, but this is due largely to the 
sizes of the backbones. Structurally, the bond lengths seen in 22 are consistent with 
previously reported compounds. The As–S bonds in 22 range from 2.23 Å to 2.29 Å. 
Compound 22 demonstrates As–π interactions which are notable due to the unusually 
close As(III)–aromatic carbon distances. However, this is now a well known 
characteristic of As–aromatic systems. For example, in a self-assembled arsenic thiolate 
macrocycle published by Darren Johnson, a close As–Caryl contact is found at 3.16 Å 
which is well within the sum of the van der Waals radii.[84, 85] To better understand the 
structure and bonding of 22, the compound is compared to 3-chloro-4H,7H-5,6-benz-
1,3,2-dithiarsepine (18). There is no π stacking interaction between the arenes in 18 in the 
solid state, whereas the short distances between centroids of adjacent arenes of 22 in the 
solid state suggest a strong intramolecular interaction. 
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Compounds 20, 21, and 22 are very similar in their As–S bond lengths. In 
comparison to organo-arsenic dithiolates there is very little difference in the bond length. 
For example, as seen in the work of Kolis et al., the As–S bond lengths range from 2.23 
to 2.28 Å in a toluene arsenic-BAL derivative, 2-p-tolyl-1,3,2-dithiarsolan-4-yl-methanol 
(23).[69] A figure of the characterized compound 23 by Kolis et al. is shown in figure 
2.15.  
There are two ways an arsenic thiolate can be thought of as a ligand. The arsenic 
atom itself can function as an electron donor through its lone pair of electrons in As(III) 
containing thiolates. The other means of ligand function would be through a reactive thiol 
on the arsenic center. It may be expected that the metal coordinated compounds have a 
considerable difference in the As–S bond distances due to the more electropositive metal 
bound to the arsenic. However, it has been shown by Khandelwal et al. that an arsenic-
metal bond does not affect the As–S bond length. This can be seen in the compound 
[Mo(η2-As(SCH2CH2S)(CO)2(η-C5H5)] (24). Even with a donor interaction of one of the 
sulfurs to the Mo center, the As–S bond lengths range from 2.25 to 2.28 Å and the S–As–
S bond angle is approximately 93.3°.[86, 87] 
The metal complexes of the 2-methyl-1,3,2-dithiarsolane (25) (four-coordinate 
As(III)) have been reported but have not been structurally characterized.[88] The structures 
of 24 and 25 can be found in figure 2.16. 
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Figure 2.4. Molecular structure of 2-chloro-1,3,2-dithiarsolane (12). Hydrogen atoms 
have been omitted for clarity. 
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Figure 2.5. Molecular structure of 2-bromo-1,3,2-dithiarsolane (13). Hydrogen atoms 
have been omitted for clarity. 
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Figure 2.6. Molecular structure of 2-iodo-1,3,2-dithiarsolane (14). Hydrogen atoms have 
been omitted for clarity. 
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Figure 2.7. Molecular structure of 2-chloro-1,3,2-dithiarsenane (15). Hydrogen atoms 
have been omitted for clarity. 
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Figure 2.8. Molecular structure of 2-bromo-1,3,2-dithiarsenane (16). Hydrogen atoms 
have been omitted for clarity. 
54 
 
Figure 2.9. Molecular structure of 2-iodo-1,3,2-dithiarsenane (17). Hydrogen atoms have 
been omitted for clarity. 
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Figure 2.10. Molecular structure of 3-chloro-4H,7H-5,6-benz-1,3,2-dithiarsepine (18). 
Hydrogen atoms have been omitted for clarity. 
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Figure 2.11. Molecular structure of 2-chloro-benzo-1,3,2-dithiarsole (19). Hydrogen 
atoms have been omitted for clarity. 
 
57 
 
Figure 2.12. Molecular structure of 1,2-bis(dithiarsolan-2-ylmercapto)ethane (20). 
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Figure 2.13. Molecular structure of tris(pentafluorophenylthio)arsen (21).  
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Figure 2.14. Molecular structure of bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)-
benzenesulfide) (22). Hydrogen atoms have been omitted for clarity. 
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Figure 2.15. Structural diagram of 2-p-tolyl-1,3,2-dithiarsolan-4-yl-methanol (23). 
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Figure 2.16. Structural diagrams of metal complexes 24 and 25.
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2.5 Aqueous Stability 
In a recent publication, arsenic triglutathione (8) as seen in figure 1.4 was found 
to form non-enzymatically from arsenite in solution with a concentration of 2 mM 
glutathione or higher. L-glutathione is a tripeptide and its IUPAC name is 2-amino-5-{[2-
[(carboxymethyl)amino]-1-(mercaptomethyl)-2-oxoethyl]amino}-5-oxopentanoic acid. It 
has been suggested that the arsenic triglutathione complexes are converted to the mono- 
and dimethyl variants by arsenic methyltransferase. It was also found that at low 
concentration (<1 mM) of glutathione, the arsenic glutathione species became unstable 
and hydrolyzed to the methyl arsenate species in vitro.[30]  
The non-enzymatic formation of arsenic triglutathione and its derivatives is important 
because it elucidates viable arsenic species in the body. The arsenic thiolates seems to be 
the preferred arsenic species in the body over arsenic oxo-species. In fact, it is suggested 
that glutathione plays an important role in arsenic transport.[89] It has been previously 
concluded that in response to arsenic, combined activation of the caspases and down-
regulation of Bcl-2 could determine the fate of B-cell leukemic cells.[5] Thus, it is of 
importance to discover whether or not the reported compounds here are maintained in 
solution and in the presence of glutathione.   
Previous work on the aqueous chemistry of 2-halo-1,3,2dithiarsolanes has been 
limited to brief descriptions of compounds formed inadvertently due to aqueous solvents. 
The overall outcome of such reactions has been the formation of arsenic trithiolates from 
the dithiolate and the conversion of one equivalent of the arsenic dithiolate into arsenous 
acid (As(OH)3) or the formation of a disulfide. A manuscript published by Sommer et al. 
in 1967 contains the earliest work on these types of compounds in aqueous solution and 
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includes the synthesis of the hydrolytically stabile 20 and similar compounds reacting in 
aqueous solution.[63] However, an in-depth study has not yet been conducted as to the 
stability of these types of compounds in an aqueous environments, let alone at various 
pHs. This aspect of the chemistry of the halo-arsenic dithiolates and arsenic trithiolates 
dictates the stability of these types of compounds in the body which is of importance if 
they are to have any chance at being effective in vivo.  
As previously stated, there is very little in the published literature on the pH 
stability of these compounds. A search of SciFinder Scholar on November 13, 2006, 
yields no publications on the topic of the pH stability of the compounds of interest. 
However, it is of note that compound 12 has been found to react with water to form 20, 
HCl, and As4O6 as can be seen in scheme 2.2.[63] Scheme 2.3 shows a stepwise scheme to 
20.  
Thus, to further test the aqueous stability of these types of compounds, this study 
has been done. The information gleaned from the study has importance in eventual 
applications of these compounds for aqueous use. It is to be made known whether or not 
these compounds should be stabile in water, and are they stabile in the presence of 
glutathione. 
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Scheme 2.2. The scheme for the hydrolysis of 12 first published by Sommer et al.[63] 
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Scheme 2.3. A two-step scheme for the hydrolysis of 12. 
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2.5.1 Method Employed 
In an attempt to elucidate the aqueous chemistry of the 2-halo-1,3,2-dithiarsenic 
heterocycles, compounds 12 and 18 were subjected to a pH study at pH 2 and 11 as well 
as a pH neutral solution. The compounds were added to buffer solutions of pH 2 and pH 
11 at room temperature, stirred, and left in the respective buffer solutions for 24 hours. 
After extracting the solutions with CH2Cl2, the organic solutions were characterized by 
GC-MS. The aqueous solutions were evaporated and the recovered solid was analyzed 
through IR and melting point. Crystals of the product of compound 12 in a buffer of pH 
11 were recovered but were unable to be solved through single crystal X-ray structure 
analysis. 
Compound 20 was added to a pH neutral solution to elucidate whether the arsenic 
trithiolate-containing compounds would be susceptible to hydrolysis at neutral pH. The 
crystals remained in the solution for two weeks, and then the solution was extracted with 
dichloromethane and analyzed by GC-MS. 
In addition, the effects of glutathione in solution were investigated. Compound 12 
was added to an aqueous solution with a stoichiometric amount of l-glutathione at room 
temperature. The solution was stirred for 4 days and then extracted with CH2Cl2. THF 
was added to the aqueous layer in an attempt to crystallize the remaining material by 
slow evaporation. The organic layer was pumped down. Acetone and THF were added to 
the solution and it was placed at -20°C for one week.   
2.5.2 Results 
Arsenic trithiolate species do not react in aqueous solution at any appreciable 
level over a two week period in pH neutral water. This has been demonstrated by 
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compound 20 not reacting in aqueous solutions and by the recrystallization of the same 
compound from an organic extraction with an almost quantitative yield of 90%.  
Halo arsenic dithiolates are not stable in aqueous solution. However, due to the 
hydrolysis being slow in pH 2 buffer solution, compound 12 can be extracted into CH2Cl2 
and is characterized by GC-MS. Table 2.1 contains the mass fragments found and 
correlates them to known species. Compound 18 was used to verify the pH stability and 
to see if the hydrolysis was as slow as seen in 12. However, compound 18 did not yield 
the same compound upon extraction. In fact, the organic fractions of compound 18, both 
at pH 2 and pH 11, yield the identical mass spectrum. They both yield the dithiolate 
ligand without the arsenic in almost quantitative yield as seen by the GC-MS spectrum. 
Therefore, it is concluded that the seven-membered ring compound is not stable in 
aqueous solution. 
The pH 11 product of 12 yielded a mixture of approximately 50% starting 
material and 50% compound 20. This result supports our findings as well as the findings 
by Sommer et al. that the primary product of the hydrolysis of compound 12 is compound 
20. However, it is of interest to note that approximately one half the starting material was 
still present even after twenty-four hours. Thus it can be stated that the hydrolysis 
reaction is relatively slow at room temperature with the concentrations used. 
Moreover, the product of the l-glutathione reaction with compound 12 also 
yielded crystalline compound 20 in 77.4% yield. The aqueous layer yielded a near-
quantitative amount of a white solid which was characterized by IR, 1H and 13C NMR as 
l-glutathione with a yield of 93.8%. 
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Thus it can be concluded that the compounds in question do not hydrolyze 
completely over the short term (24 hours with substantial degradation) and the interaction 
of l-glutathione does not inhibit hydrolysis of the chloride to the arsenous acid and 
compound 20. The aqueous availability of the active arsenic species is essential to having 
any chance of biological efficacy. As can be seen from the reported work here, the 
arsenic center can react in aqueous solution.    
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Table 2.1. Mass fragments found in aqueous study. 
 pH 2 - CH2Cl2 pH 7 - CH2Cl2 pH 11 - CH2Cl2 
Compound 12 202 (AsCl(SCH2CH2S))+ 202 (AsCl(SCH2CH2S))+  
 167 As(SCH2CH2S))+ 167 As(SCH2CH2S))+ 167 As(SCH2CH2S))+ 
 139 AsS2+ 139 AsS2+ 139 AsS2+ 
 107 AsS+  107 AsS+  107 AsS+  
Compound 18 168 (SCH2)2C6H4+ 168 (SCH2)2C6H4+ 168 (SCH2)2C6H4+ 
 104 (CH2)2C6H4+ 104 (CH2)2C6H4+ 104 (CH2)2C6H4+ 
Compound 20  167 (AsSCH2CH2S)+  
Mass spectra obtained in positive ion mode. Ions created by EI. 
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2.6 Conclusion 
The ease with which the six-membered rings break upon addition of base and the 
inability to form and isolate the seven-membered ring compound implies that the five-
membered ring is the least reactive in the series of n = 2, 3, and 4 in the alkylene linkage 
in AsX(S(CH2)nS) where X is the halide. Conversely, there is no evidence to show that 
the dithiarsepane (As(S(CH2)4S)) ring, if formed, is stable. The possibility of 
rearrangement into an oligomeric form seems more likely due to the mass spectral data 
obtained from failed attempts at the synthesis of the 2-chloro-dithiarsepane. After several 
attempts, 2-chloro-1,3,2-dithiarsepane was not isolated and characterized. When arsenic 
trichloride and 1,4-dithiobutane are combined at room temperature a white emulsion 
forms which when extracted into CS2, gives much higher molecular weight species than 
would be expected for 2-chloro-1,3,2-dithiarsepane.  
Results from the successful syntheses reported in the present work indicate that 
the As–S bonds in cyclized five-membered halo arsenic dithiolates are both somewhat 
acid and base stable but undergo immediate salt eliminations and redistribution with 
larger cycles in both acidic and basic conditions. Certain combinations of chelate length 
are more susceptible to breakage of the chelate As–S bonds in the salt elimination 
process. This is most obvious in the synthesis of arsenic trithiolates from their dithiolate 
derivatives. The truncated As–S bonds shown in these compounds (bond lengths within 
the sum of the covalent radii) and the slightly elongated bond lengths of the arsenic 
halides indicate the unequal orbital hybridization as called for by Bent’s rule. 
Unfortunately, the variances in bond lengths are inconclusive due to experimental error. 
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Compounds 12–19 display an axial alignment of the halide on the arsenic center 
with respect to the ring. As can be seen from the structural data, bond distances and 
angles are not affected by the identity of the terminal halide. This explains the 
spectroscopic similarity between 12, 13, 14 and 19 and between 15, 16 and 17.  
Compound 20 seems to be the preferred product in reactions involving ring 
hydrolysis of five-membered rings. This is due to the ease of hydrolysis of the terminal 
halide analogues and the stability of the trithioarsenic moiety to hydrolysis. This stability 
was also seen in the pharmacological attributes of non-alkylating dithiarsenicals which 
were tested for efficacy against cancers as early as 1966.[1] It is interesting to note that 
compounds which were found then to be ineffective against cancers have recently been 
shown to have just such an efficacy.[10]  
In compound 12, it was previously postulated that the 2-chloro-1,3,2-dithiarsolane 
is first hydrolyzed at the As–Cl bond followed by breakage of the As–S bond by water, 
which then provides a free sulfhydryl group which can react with another equivalent of 
12 to eliminate HCl.[62] However water does not seem to be the only solvent that will 
function successfully to break the As–S bond since in the present case this occurs in CCl4 
with the addition of excess NaHCO3, which means a wide range of solvents both polar 
and non-polar should be conducive to the As–Cl bond breakage. 
There has been some interest in compound 17 in radioarsenic labeling where an 
72As atom would be used as a positron emitter as it decays to 72Ge.[90] It has been 
suggested that compound 17 could be used to label biomolecules with 72As.  This would 
be the first “no carrier added” arsenic labeling and could find use in positron emission 
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tomography. However, it is not noted whether the compound is stable to hydrolysis at 
biologically relevant pH and Eh or whether it needs to be to deliver the nuclide.  
Compound 21 was synthesized to determine the bond length of the As–S bonds in 
the absence of a ring structure yet retaining the electron-withdrawing power of a pseudo-
halide. It was thought that the addition of strongly electron withdrawing groups would 
shorten the As–S bond. Pentafluorothiophenol, which was used in the synthesis of 
compound 21, has been used to make various metal complexes including arsenic 
complexes.[91, 92] However, only the elemental analysis data and the melting point were 
reported previously. This work sought general information in the basic chemistry of As–S 
bonding and specifically whether the presence of fluorine would lead to stronger 
bonding. In theory, arsenic trithiolates mimic the bonding between arsenic and three 
glutathione molecules. Nonetheless, 21 exhibits very similar As–S bonds to those in 20. 
The lack of any real variation in the As-S bond length in 21 indicates that the 
pentafluorothiophenyl group bound to the arsenic yields similar arsenic-sulfur bonds as 
those found in the cyclized arsenic dithiolates. The inductive effect which is defined by 
the International Union of Pure and Applied Chemistry (IUPAC) as the transmission of 
charge through a chain of atoms in a molecule by electrostatic induction does not seem to 
be noticeable through the sulfur atom. Sulfur, which is considered in hard-soft acid-base 
theory to be a soft base, does not transmit charge due to said softness. 
Compound 22 demonstrates intramolecular π-stacking in the solid state. The 
crystal structure reveals channels of alternating benzene rings. As a coordinating ligand 
through the arsenic lone pairs, or as a basis for metallocenes in molecular self assembly, 
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this molecule could have interesting utility as a ligand. Also, compound 22 is the first 
reported arsenic trithiolate compound with an intramolecular organic disulfide linkage. 
The fully characterized compounds reported here provide compounds for 
comparison with arsenic glutathione metabolites and of what are up to this point other 
speculated arsenic thiolate metabolites in living systems. It has been determined that the 
As–S linkages and the As–Cl bonds are reactive in aqueous conditions. Based on what 
has been demonstrated, the bonding interactions of glutathione to arsenic in the 
heterocyclic compounds is not strong enough to overcome the formation of an arsenic 
trithiolate in the presence of 1,2-dithioethane. This suggests that the overall toxicity seen 
for arsenic thiolates in leukemia cells in due primarily to the arsenic moiety.    
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Chapter 3 
 
Antimony Dithiolates and Trithiolates 
 
3.1 Overview 
Antimony and arsenic thiolate chemistry share several similarities. Due to the 
similarities between arsenic and antimony in size, electronegativity, reactivity and 
reaction preferences, they both exhibit very comparable chemistry. Like arsenic, the most 
common oxidation states of antimony are (III) and (V). Nonetheless, examples of Sb(0) 
and Sb (-III) are known as well, for example, elemental antimony and SbH3 respectively. 
Antimony thiolate chemistry, while not possessing the wide range of biological activity 
of arsenic has interesting features. For example, antimony dithiolates tend to adopt higher 
coordination numbers than arsenic which are of structural interest. In addition, it is 
postulated that antimony trioxide forms antimony triglutathione in vivo which is 
analogous to arsenic. The molecular coordination geometries usually seen for antimony 
are distorted trigonal pyramidal, tetrahedral and octahedral. The higher range of possible 
coordination numbers for antimony is often reached by secondary interactions. The 
synthesized antimony compounds are to be compared against their arsenic analogues but 
also seen as their own separate entity.  
3.1.1 Fundamental Properties of Antimony 
Antimony is a grayish white metalloid. It has the atomic number of 51, an atomic 
mass of 121.760 g/mol and two stable isotopes, 121Sb and 123Sb. Antimony shares its 
outer electron configuration with nitrogen, phosphorus, arsenic and bismuth. Usually, it is 
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grouped together with the latter two elements due to similarities in chemistry, reactivity, 
size and similarities in coordination chemistry. 
3.1.2 Chemical and Physical Properties of Antimony 
Antimony has a number of allotropes. α-Antimony is crystalline and isostructural 
with α-arsenic and α-bismuth. In addition to α-antimony, there are five more forms of 
elemental antimony. β-Antimony is what is normally referred to as rhombohedral 
antimony or just antimony and is a silver-white solid with a high metallic luster. 
3.1.3 Geochemistry of Antimony 
The most important antimony-containing ore is stibnite, Sb2S3.The abundance of 
antimony in crustal rock is 0.2 ppm, which places it sixty-second in abundance compared 
to the other elements. Antimony can occasionally be found in nature as a free element. 
There are several other minerals containing antimony including ullmanite (NiSbS), 
livingstonite (HgSb4S8), tetrahedrite (Cu3SbS3), and wolfsbergite (CuSbS2). Small 
amounts of the oxides are formed by weathering and include valentinite (Sb2O3), 
cervanite (Sb2O4), and stibiconite (Sb2O4.H2O).  
3.1.4 Biological Activity of Antimony 
Antimony is not as biologically active as arsenic. Sb2O3 has an acute oral toxicity 
which is much higher than the achievable dosing limit of 28 g/kg and has been found not 
to be genotoxic in vivo.  
In fact, Sb (V) compounds are used as the drug of choice in treating particular 
ailments such as human leishmaniases. Leishmaniases are a group of diseases which are 
caused by the invasion of a human host by the parasite belonging to the genus leishmania. 
There are approximately two million new cases every year. There are two forms; 
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cutaneous and visceral leishmaniasis. The cutaneous form is usually manifested as sores 
on the skin. The visceral form is manifest by fever, weight loss, and an enlarged spleen 
and liver.  
The standard procedure is treatment with antimony (V) compounds such as 
meglumine antimonate or sodium stibogluconate.[93] It should be noted that the structure 
of meglumine antimonite is poorly understood although it has been in use for over fifty 
years.[94] It has been suggested that glutathione (GSH) reduces the previously mentioned 
meglumine antimoniate drug to Sb(GS)3.[93] The formation of Sb(GS)3 has also been 
shown to occur with potassium antimony (III) tartrate.[95] Cysteine, cysteinyl-glycine and 
tripanothione have also been shown to reduce Sb (V) containing complexes to their Sb 
(III) derivatives.[96] 
3.1.4.1 Biomethylation of Antimony 
The monomethylated and dimethylated antimony species have been seen as 
intermediates in the methylation pathway to trimethylstilbine. There is some evidence 
which suggests that antimony proceeds via the Challenger mechanism which can be seen 
in scheme 1.1, and is the accepted arsenic biomethylation pathway in the body.[97]  
3.2 Antimony Thiolates 
In the literature, antimony-sulfur covalent bond lengths fall in the range of 2.40-
2.50 Å for single bonds and result in compounds with a trigonal pyramidal molecular 
geometry. Very little is known about antimony (III) dithiolates. In fact, a search of 
heterocyclic compounds containing the S–Sb–S moiety with Sb in the (III) and (V) 
oxidation states yields 204 journal references in Scifinder Scholar. Most of these 
compounds are coordination compounds with CN of 4-6. However, there are several 
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antimony thiolate compounds which are similar in structure to compounds 12-22 reported 
here as well. For example, the IR and Raman spectra of the simple antimony analogues of 
12, 13 have been reported.[74]  
The compounds synthesized here are to be compared against other known 
antimony dithiolates and trithiolates such as a compound reported by Wandiga et al. in 
which an antimony (V) derivative bound to three benzenedithiol ligands has been 
structurally characterized.[80]  
When the Sb–S and Sb–Cl bond lengths in the compounds are also to be 
compared to an eight-membered ring compound published by Vela et al., who obtained a 
crystal structure of the antimony dithiolate.[98] 
3.3 Experimental Section 
3.3.1 General  
SbCl3 and SbF3 were purchased from Aldrich and used as received. The dithiols 
were obtained from Aldrich and were used as delivered without further purification. All 
manipulations were carried out using standard inert atmosphere techniques under a 
nitrogen atmosphere. NMR spectra were obtained at room temperature in CDCl3 on 
Varian Gemini 200 or Varian Innova 400 NMR spectrometers. Chemical shifts are 
reported in ppm, relative to tetramethylsilane. FT-IR spectra were recorded as KBr pellets 
on a Varian Spec 9800. Melting points were obtained on a Mel-Temp melting point 
apparatus. 
X-ray diffraction data were collected at 90 K on a Nonius Kappa CCD 
diffractometer unit using Mo Kα radiation from colorless, regular-shaped crystals 
mounted in Paratone-N oil on glass fibers. Initial cell parameters were obtained using 
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DENZO from 1° frames and were refined by a least-square scheme using all data-
collection frames (SCALEPACK).[70] The structures were solved by direct methods 
(SHELXL-97) and completed by difference Fourier methods (SHELXL-97).[71] 
Refinement was performed against F2 by weighted full-matrix least-square. Hydrogen 
atoms were placed at calculated positions using suitable riding models with isotropic 
displacement parameters derived from their carrier atoms. Non-hydrogen atoms were 
refined with anisotropic displacement parameters. Atomic scattering factors were taken 
from the International Tables for Crystallography volume C.[72] Details of crystal data, 
data collection, and structure refinement are listed in the appendix. 
2-Chloro-benzo-1,3,2-dithiastibole (26) 
1,2-Benzenedithiol (1.00 g, 7.03 mmol) in 10 mL benzene was added drop-wise to 
antimony trichloride (1.60 g, 7.01 mmol) in 30 mL benzene at room temperature. The 
solution turned yellow upon addition. The solution was stirred for an hour under a 
nitrogen atmosphere. Then 15 mL of methanol was added to the solution to dissolve the 
solid present. Approximately 10 mL of solvent was then removed via vacuum. Crystals 
formed shortly thereafter. The crystals were kept at room temperature. The solution was 
filtered and 0.99 g of a crystalline material was obtained with a yield of 47.4 %. Mp: 
170.0-172.0 oC. 1H NMR (CDCl3, ppm): δ 7.560 (benzene, m, 2H), δ 7.092 (benzene, m, 
2H). 13C NMR (CDCl3, ppm): δ 130.23 (=CH-), δ 125.77 (=CH-). IR (ν, cm-1, KBr): 
3045.79 (w), 1942.56 (w), 1909.15 (w), 1790.01 (w), 1603.65 (w), 1549.47 (w), 1442.79 
(vs), 1429.02 (w), 1421.04 (s), 1249.39 (m), 1100.26 (m), 1028.58 (m), 940.61 (w), 
744.93 (vs), 650.13 (m), 463.08 (m), 426.67 (m). Mass spectra (GC-MS): 261 
(SbSC6H4S)+, 185 (SbS2)+, 153 (Sb-S)+.  
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Bis(2-(1,3,2-benzodithistibol)-1,2-benzenedithiol (27) 
1,2-Benzenedithiol (0.59 g, 4.15 mmol) in 1 mL benzene was added drop-wise to 
antimony trifluoride (0.64 g, 3.58 mmol) in 40 mL benzene at room temperature. A 
yellow precipitate formed upon addition. The solution was stirred for an hour under a 
nitrogen atmosphere. 20 mL of methanol was added to the solution. The solution was 
filtered yielding 0.88 g of material with a percent yield of 47.4 %. Mp: 250.0-252.0 oC 
Crystals were obtained by re-dissolving the solid in a 70/30 CS2/Benzene solution. The 
crystals were kept at room temperature. The crystals are as of yet unsuitable for single 
crystal X-ray structure determination.  1H NMR(CS2/CDCl3, ppm, 400 MHz): δ 7.504 
(benzene, q, 4H), δ 7.366 (benzene, q, 2H), δ 7.069 (benzene, q, 4H), δ 7.022 (benzene, 
q, 2H). 13C NMR (CDCl3, ppm, 100 MHz): δ 132.469 (=CH-), δ 125.448 (=CH-), 
δ 94.332 (=CH-). IR (ν, cm-1, KBr): 3422.91 (b), 3046.24 (m), 1927.19 (w), 1626.47 (m), 
1548.87 (m), 1439.82 (vs), 1415.63 (s), 1269.15 (w), 1244.67 (m), 1158.23 (w), 1101.55 
(m), 1032.68 (m), 931.79 (w), 853.77 (w), 747.30 (vs), 679.50 (w), 653.91 (m),623.19 
(w), 470.32 (m), 428.57 (m). Mass spectra (GC-MS): 337 (SbS2C6H4+CS2)+, 261 
(SbS2C6H4)+, 108 (SC6H5S)+.  
3.4 Results 
3.4.1 Synthesis and Spectroscopy 
Antimony di- and tri-thiolates are of interest due to their analogous chemistry as 
compared to arsenic and their own usefulness in both biological and industrial 
environments. Structural representations of the compounds 2-chloro-benzo-1,3,2-
dithiastibole (26) and bis(2-(1,3,2-benzodithiastibol)-1,2-benzenedithiol (27) are shown 
in figure 3.1. The reaction schemes for each synthesis are shown in scheme 3.1. 
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There are two phenyl proton signals in the 1H NMR for compound 26, due to the 
symmetry of the molecule. In the 13C spectrum, the lack of protons on the carbons 
attached to the sulfur reduces the NOE effect and thus those carbons are not seen. The IR 
spectrum of 26 shows the corresponding C–S stretches at 650 cm-1, and Sb–S stretches at 
463 cm-1 and 427 cm-1 respectively.  
In compound 27, the 1H NMR shows four signals that integrate in the ratio 2:1:2:1 
between 7.50 and 7.02 ppm, which corresponds to a bridging structure as shown in figure 
3.1. The IR spectrum shows the expected ring stretches for the S–Sb–S five membered 
ring at 470 and 428 cm-1. The expected C–S stretches at 679 and 654 cm-1 are also seen. 
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 Figure 3.1. Structural formulae for compounds 26 and 27.  
 
 
+ 3 HSC6H4SH (l)
Benzene
2 SbF3 (s) + 6 HF (g)(SC6H4S)Sb(SC6H4S)Sb(SC6H4S) (s)
+ HS(C6H4)SH (l)
Benzene
SbCl3 (s) SbCl(SC6H4S) (s) + 2 HCl (g)
 
Scheme 3.1. The synthetic routes to the antimony di- and tri-thiolate compounds. 
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3.4.2 Structure 
Compound 26 crystallizes in the space group Pbca. The Sb–S bond distances are 
approximately 2.41 Å and the Sb–Cl bond distance is 2.46 Å. These values fall in the 
expected range for Sb–S and Sb–Cl bonds. Compound 26 has intermolecular Sb…Cl 
interactions that are 0.3 Å within the sum of the van der Waals radii. With these contacts 
Sb takes on a highly distorted trigonal bypyramidal geometry. The structure of 26 is 
shown in figure 3.2.  However, a similar reaction in which the Sb-ligand ratio was 1:2, 
yielded an antimony (V) derivative bound to three benzenedithiol ligands which has been 
structurally characterized.[80] This compound, in which antimony has a coordination 
number of six, exists as an anion in the form of ((MeC6H3S2)3Sb)-.  
When the Sb–S and Sb–Cl bond lengths in compound 26 are compared to 
compound 28 published by Vela et al., which can be seen in figure 3.3, the values are 
quite similar and both compounds display secondary interactions within the sum of the 
van der Waals radii.[98] This is in keeping with the higher coordination numbers that are 
possible for antimony in comparison to arsenic. The Sb–Cl bond distances are 
comparable at 2.46 Å in 26 to 2.48 Å in 28. The Sb–S bonds are also very similar at 2.40-
2.41 Å in 26 versus 2.45-2.46 Å in 28. The slightly larger bond lengths for 28 are most 
likely due to the larger ring size; a five-membered versus an eight-membered ring.  
Crystalline compound 27 was obtained but was not able to be structurally 
characterized due to a lack of a crystal of high enough quality. In a previous attempt with 
a stoichiometry of 1:1, the intended synthetic compound was a 2-fluoro-benzo-
dithistibane. However, symbiosis makes it much more difficult to stabilize a 2-fluoro 
analogue. Once the much softer ligands (sulfurs) form bonds to the antimony, the last Sb–
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F bond becomes extremely labile. The compound has been recrystallized with varying 
degrees of success from several solvents including CS2, benzene, CCl4, toluene, CH2Cl2, 
CH3OH, and several combinations of these. Unfortunately, at this time a crystal of X-ray 
quality has not been obtained. 
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Figure 3.2. Molecular structure of 2-chloro-benzo-1,3,2-dithiastibole (26).  
 
 
 
.
S
Sb S
S
Cl
28  
Figure 3.3. Structural formula of compound 28.[98] 
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3.5 Conclusion 
These compounds shown here provide some new examples of antimony thiolates. 
The antimony dithiolate compound (26) is very similar in structural and spectroscopic 
characteristics to its arsenic analogue. This can be seen in the Sb–S bond lengths in 
comparison to the As–S bond lengths and similarities in S-M-S bond angles where M = 
As, Sb. For example, the S–As–S bond angle is 92.94° in 19, whereas in 26, the S–Sb–S 
bond angle is 88.39° and the Sb–S bond distances are approximately 0.2 Å longer than 
their corresponding As–S bond distances.   
The antimony trithiolate is similar to its arsenic analogues in its spectroscopic 
characteristics. Compound 27 demonstrates that the antimony trifluoride species is 
similarly reactive as its arsenic analogue. Both starting materials yield trithiolates instead 
of the 2-fluoro dithiolate analogs. This is most likely due to the M-F bond being labile 
and the initial formation of five-membered ring systems which can undergo 
intermolecular thiolate-disulfide interchange as reported by Whitesides et al, and 
symbiotic interactions.[99] It is interesting to note that to access 
((SCH2CH2S)As(SCH2CH2S)As(SCH2CH2S)) 20 involve hydrolytic degradation of the 
formed ring. It is speculated by the author that a similar reaction takes place in the 
synthesis of compound 27 due to the use of CH3OH as a solvent.   
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Chapter 4 
 
Conclusions and Future Research 
 
4.1 Conclusions 
As stated previously, based on the fact that arsenic compounds have biological 
activity, it is suggested that novel cyclized arsenic thiolates can be synthesized with the 
appropriate characteristics as to be potentially useful as medicinal agents as well as 
provide new structural and reaction information for the arsenic thiolate species. The 
target compounds are those with arsenic bound by two thiolate groups in a cyclic system 
and thus they do not allow the release of arsenic but, with a potentially reactive halide 
group, still retain their biological activity by providing a site for glutathione to bind. 
What is required is to demonstrate that these compounds can be prepared and that the 
dithiolate unit would remain intact under aqueous conditions. This hypothesis was 
confirmed in a recent patent where compounds such as S-dimethylarsino-thiosuccinic 
acid, S-dimethylarsino-salicylic acid, and S-(dimethylarsino) glutathione were patented 
for use as anti-leukemic drugs.[11] In general, the patent was for organic arsenicals 
containing an arsenic thiolate.  
Methods for administering the compounds of interest have been contemplated. 
The more probable applicable administration methods would seem to be direct 
administration by injection, intratumoral, and administration to the tumoral vasculature. 
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Once the compound is administered in close proximity to the tumor, the halide most 
likely will be hydrolyzed and a new As–S bond form. This newly formed bond would 
most likely be between the arsenic dithiolate and cysteine or glutathione. 
In terms of structural information obtained, compounds 12-19 display an axial 
alignment of the halide on the arsenic center with respect to the ring. As can be seen from 
the structural data, bond distances and angles are not affected by the identity of the 
terminal halide. This explains the spectroscopic similarity between 12, 13, 14 and 19 and 
between 15, 16 and 17. Compound 20 seems to be the preferred product in reactions 
involving ring breakage of five-membered rings. This is due to the stability of the 
trithioarsenic moiety versus a halo-arsenic dithiolate species which plays a large role in 
how the reactivity of arsenic dithiolates is assumed to occur. Compound 21 was 
synthesized to determine the bond length of the As–S bonds in the absence of a ring 
structure yet retaining the electron-withdrawing power of a pseudo-halide. It was thought 
that the addition of large electron withdrawing groups would shorten the As–S bond. 
Nonetheless, compound 21 exhibits very similar As–S bonds to those in 20. This equates 
the pentafluorothiophenyl group in terms of its effect on the arsenic-sulfur bond as to 
arsenic-sulfur bonds found in the cyclized arsenic dithiolates. Compound 22 
demonstrates intramolecular π-stacking in the solid state. The crystal structure reveals 
channels of alternating benzene rings. As a coordinating ligand through the arsenic lone 
pairs, or as a basis for metallocenes in molecular self assembly, this molecule has the 
correct structure as to be of interesting utility as a ligand which should be assessed in the 
near future. Also, compound 22 is the first reported arsenic trithiolate compound with an 
intramolecular organic disulfide linkage. 
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The compounds reported here provide a basis for comparison with arsenic glutathione 
metabolites and of what are up to this point other speculated arsenic thiolate metabolites. 
It has been determined that the As–S linkages can be reactive dependent on the As–X 
bond and the environmental and biological conditions. 
The antimony dithiolate and trithiolate compounds are very similar in structural 
and spectroscopic characteristics to their arsenic analogues. This can be seen in the Sb–S 
bond lengths in comparison to the As–S bond lengths and similarities in S–M–S bond 
angles where M = As, Sb. For example, the S–As–S bond angle is 92.94° in 19, whereas 
in 26, the S–Sb–S bond angle is 88.39° and the Sb–S bond distances are approximately 
0.2 Å longer than their corresponding As–S bond distances.    
Compound 27 demonstrates that the antimony trifluoride species is similarly 
reactive as its arsenic analogue. Both starting materials yield trithiolates instead of the 2-
fluoro-1,3,2-dithiarsenic or antimony analogue. This is most likely due to the M–F bond 
being labile and the initial formation of five-membered ring systems which can undergo 
intermolecular thiolate-disulfide interchange as reported by Whitesides et al, and 
symbiotic interactions.[99]  
These compounds provide some new examples of antimony thiolate compounds. 
Little is known about the biological activity of such compounds. As has been stated 
previously, uses for antimony compounds as an anti-parasitic drug are well known but 
with the newly rediscovered efficacy of their arsenic analogues, these antimony 
compounds warrant further investigation into the biological properties as well as 
continued synthesis of new antimony thiolate compounds for structural information. 
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4.2 Future Research 
4.2.1 Arsenic Thiolate Interactions in Blood Serum 
Now that a series of arsenic dithiolates have been obtained and fully 
characterized, it is of interest to explore their aqueous chemistry, especially towards 
thiols containing biologically relevant species such as cysteine and glutathione and blood 
serum. The pH stability of 12 and 18 has been discussed. Yet, a much more 
encompassing investigation would be applicable to ascertain the viability of the 2-halo 
arsenic and antimony dithiolates as aqueous stabile compounds stable for medicinal 
purposes. Their stability and interactions with other species in blood serum would give 
insight into the biological aspects of chelate therapy as such those based on BAL and 2,3-
dimercaptosuccinic acid as well as in vitro analyses of 2-halo antimony dithiolates for 
anti-parasitic activity. Based on what is known about the use of compound 17 in radio-
isotope labeling, there may be little reactivity of the reported compounds in biologically 
relevant aqueous conditions. This is based on the work of Rosch et al. in which they 
proposed using compound 17 in vivo. However, the hydrolysis of the 2-halo-arsenic 
dithiolates yields arsenic trithiolate species, as well as the original 2-halo dithiolate 
analogue. Thus the active compounds in vivo are hydrolyzed derivatives of the starting 
compounds. As has been tentatively reported elsewhere in this manuscript, the arsenic 
trithiolates are less susceptible to hydrolysis and therefore do not react in water at pH 7. 
However, they may still be active.  
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4.2.2 Environmental Applications  
A water-stable vicinal dithiol could be used as a remediation technology. Polymer 
attachment of a vicinal dithiol would make a very strong filtration column for arsenic in 
water. Work on just such a system is currently underway in the Atwood group at the 
University of Kentucky. However, vicinal dithiols react with several other ions as well. 
Thus, a system with some level of ion specificity would need to be devised. The synthesis 
of such a system could involve the attachment of BAL or some other vicinal dithiol with 
an available –OH to be used to tether the compound to a polymer surface. If the 
compound is robust, a dehydration reaction would be a facile means of synthesizing the 
polymer. 
Alternatively, a vicinal dithiol could be adsorbed onto silica or activated carbon. 
This would have similar drawbacks to the polymer-based filtration system but it may be 
more facile to synthesize. The synthesis of such a system would involve dissolving the 
dithiol and soaking the substrate in a concentrated solution followed by blowing off the 
solvent. Then the impregnated silica or activated carbon could be used in a gravity 
column. 
4.2.3 Solid State 75As NMR  
Arsenic only has one stable isotope, 75As. This isotope is NMR active with a 
quantum spin number of 3/2 and an NMR receptivity value relative to 13C of 143. The 
75As relative frequency at 7.2 Tesla is 51.391 MHz. There has been very little solid state 
75As NMR done. This may be due to the need for a highly symmetric environment for the 
nucleus to obtain resolvable line widths.   
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The question of whether arsenic contamination in a given environment is in the 
+3 or +5 oxidation states dictates the measures taken under EPA guidelines. Therefore, 
there may be application for this technique in the speciation of a solid compound. The 
application for such a technology would have a large impact on remediation measures 
taken. To this end, we are currently seeking a collaborator to undertake this aspect of the 
research. 
4.2.4 Activity of Cyclized Arsenic Thiolates Towards Leukemic Cells 
With the recent publication of several compounds sharing structural similarities 
with the reported compounds, it would be prudent to take several of the synthesized 
compounds and test for antileukemic activity.[2, 4-10] This could be done in collaboration 
with groups already active in the field such as John Yannelli, an associate professor of 
internal medicine who is currently working on gene therapy for leukemia at the 
University of Kentucky. Also, it has been seen in the literature that antimony and bismuth 
complexes similar to the arsenic compounds reported here may have some medicinal uses 
as anti-parasitic compounds. 
4.2.5 Bismuth Dithiolate Chemistry 
Bismuth analogues of the series of compounds discussed here exist for some 
particular compounds such as the Bi analogues to 12, 13, 19, and 26. However, several 
more have not been synthesized such as the bismuth analogue of compounds 22 and 27. It 
would be beneficial to continue of this work with bismuth. Bismuth chemistry is strongly 
influenced by the lanthanide contraction. 
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The lanthanide contraction is the weaker shielding of the nucleus by the f-orbitals 
electrons due to the directionality of said orbitals. The s-orbitals are localized at the 
nucleus, thus experiencing a stronger attractive effect. The lanthanide contraction plays 
an important role in the availability of the Bi (III) oxidation state in dithiolate chemistry. 
In essence, the perceived nuclear charge is higher than it ought to be. This leads to a 
much stronger attraction between the outer electrons and the nucleus, making it harder to 
oxidize the element. Also, the s-p orbital splitting increases as the size of the nucleus 
increases which is exacerbated by the lanthanide contraction, thus making these 
compound an interesting group to study.  
The reactivity of bismuth is considerably lower than that of arsenic and antimony. 
Therefore, other more energetic techniques may be required such as reflux and the 
inclusion of base to deprotonate the thiols in a reaction with BiCl3. One such reaction 
could involve the use of sodium ethoxide to accomplish the deprotonation of a 
stoichiometric ratio of 3:1 benzene-1,2-dithiol and BiCl3. 
4.2.6 Use as Ligands 
The metal coordinated 2-methyl-1,3,2-dithiarsolanes have been synthesized but 
there has been no structural characterization of this class of compounds.[88] The metal-
arsenic bond lengths can be estimated in such a system yet a structural determination of a 
representative compound would be definitive. As such, a need for the structural 
determination of such a compound exists.  
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Figure A1. Packing diagram for 2-chloro-1,3,2-dithiarsolane (12). Hydrogen atoms are 
omitted for clarity.  
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Table A2. Crystal data and structure refinement for 2-chloro-1,3,2-dithiarsolane (12) 
Compound 2-chloro-1,3,2-dithiarsolane 
Empirical formula  C2H4AsClS2 
Formula weight 202.54 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Monoclinic 
Space group P21/c 
a (Å) 9.7563(2) 
b (Å) 7.0930(1) 
c (Å) 9.2864(2) 
α (°) 90 
β (°) 111.9504(9) 
γ (°) 90 
Volume (Å3) 596.05(2)  
Z 4 
Calculated density (Mg/m3) 2.257  
Absorption coefficient (mm-1) 6.702 
F(000) 392 
Crystal size (mm) 0.25 x 0.20 x 0.15 
Theta range for data collection (°) 2.25 to 25.00 
Limiting indices -11 ≤ h ≤ 11, -8 ≤ k ≤ 8, -10 ≤ l ≤ 11 
Reflections collected 1979 
Unique reflections 1058 [R(int) = 0.0198] 
Completeness to theta = 25.00 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.4330 and 0.2851 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1058 / 0 / 56 
Goodness-of-fit on F2 1.086 
Final R indices [I>2σ(I)] R1 = 0.0142, wR2 = 0.0313 
R indices (all data) R1 = 0.0156, wR2 = 0.0318 
Extinction coefficient 0.0133(6) 
Largest diff. peak and hole 0.229 and -0.381 e.A-3 
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Table A3. Bond lengths (Å) and angles (°) for 2-chloro-1,3,2-dithiarsolane (12)            
Atoms Bond lengths (Å) 
As(1)-S(2) 2.2088(5) 
As(1)-S(1) 2.2402(5) 
As(1)-Cl(1) 2.2669(4) 
S(1)-C(1) 1.8343(19) 
S(2)-C(2) 1.8193(18) 
C(1)-C(2) 1.505(2) 
C(1)-H(1A) 0.9900 
C(1)-H(1B) 0.9900 
C(2)-H(2A) 0.9900 
C(2)-H(2B) 0.9900 
  
Atoms Bond angles (°) 
S(2)-As(1)-S(1) 93.398(18) 
S(2)-As(1)-Cl(1) 98.857(17) 
S(1)-As(1)-Cl(1) 97.445(18) 
C(1)-S(1)-As(1) 100.45(6) 
C(2)-S(2)-As(1) 96.81(6) 
C(2)-C(1)-S(1) 111.35(13) 
C(2)-C(1)-H(1A) 109.4 
S(1)-C(1)-H(1A) 109.4 
C(2)-C(1)-H(1B) 109.4 
S(1)-C(1)-H(1B) 109.4 
H(1A)-C(1)-H(1B) 108.0 
C(1)-C(2)-S(2) 110.49(12) 
C(1)-C(2)-H(2A) 109.6 
S(2)-C(2)-H(2A) 109.6 
C(1)-C(2)-H(2B) 109.6 
S(2)-C(2)-H(2B) 109.6 
H(2A)-C(2)-H(2B) 108.1 
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Figure A4. Packing diagram for 2-bromo-1,3,2-dithiarsolane (13). Hydrogen atoms are 
omitted for clarity.  
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Table A5. Crystal data and structure refinement for 2-bromo-1,3,2-dithiarsolane (13) 
Compound 2-bromo-1,3,2-dithiarsolane 
Empirical formula  C2H4AsBrS2 
Formula weight 247.00 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Orthorhombic 
Space group P212121 
a (Å) 6.7428(1) 
b (Å) 9.5235(1) 
c (Å) 9.5753(1) 
α (°) 90 
β (°) 90 
γ (°) 90 
Volume (Å3) 614.878(13)  
Z 4 
Calculated density (Mg/m3) 2.668  
Absorption coefficient (mm-1) 12.562 
F(000) 464 
Crystal size (mm) 0.23 x 0.22 x 0.20 
Theta range for data collection (°) 3.02 to 27.48 
Limiting indices -8 ≤ h ≤ 8, -12 ≤ k ≤ 12, -12 ≤ l ≤ 12 
Reflections collected 1405 
Unique reflections 1405 [R(int) = 0.0590] 
Completeness to theta = 25.00 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.188 and 0.162 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1405 / 0 / 56 
Goodness-of-fit on F2 1.121 
Final R indices [I>2σ(I)] R1 = 0.0131, wR2 = 0.0324 
R indices (all data) R1 = 0.0131, wR2 = 0.0324 
Absolute structure coefficient 0.028(8) 
Extinction coefficient 0.0122(6) 
Largest diff. peak and hole 0.324 and -0.266 e.A-3 
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Table A6. Bond lengths (Å) and angles (°) for 2-bromo-1,3,2-dithiarsolane (13)            
Atoms Bond lengths (Å) 
Br(1)-As(1)  2.4196(3) 
As(1)-S(1) 2.2092(6) 
As(1)-S(2) 2.2278(6) 
S(1)-C(1) 1.820(2) 
S(2)-C(2) 1.829(2) 
C(1)-C(2) 1.513(3) 
C(1)-H(1A) 0.9900 
C(1)-H(1B) 0.9900 
C(2)-H(2A) 0.9900 
C(2)-H(2B) 0.9900 
  
Atoms Bond angles (°) 
S(1)-As(1)-S(2)    94.03(2) 
S(1)-As(1)-Br(1) 99.449(18) 
S(2)-As(1)-Br(1) 97.948(18) 
C(1)-S(1)-As(1) 96.91(8) 
C(2)-S(2)-As(1) 100.52(7) 
C(2)-C(1)-S(1) 110.75(16) 
C(2)-C(1)-H(1A) 109.5 
S(1)-C(1)-H(1A) 109.5 
C(2)-C(1)-H(1B) 109.5 
S(1)-C(1)-H(1B) 109.5 
H(1A)-C(1)-H(1B) 108.1 
C(1)-C(2)-S(2) 111.33(15) 
C(1)-C(2)-H(2A) 109.4 
S(2)-C(2)-H(2A) 109.4 
C(1)-C(2)-H(2B) 109.4 
S(2)-C(2)-H(2B) 109.4 
H(2A)-C(2)-H(2B) 108.0 
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Figure A7. Packing diagram for 2-iodo-1,3,2-dithiarsolane (14). Hydrogen atoms are 
omitted for clarity. 
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Table A8. Crystal data and structure refinement for 2-iodo-1,3,2-dithiarsolane (14) 
Compound 2-iodo-1,3,2-dithiarsolane 
Empirical formula  C2H4AsIS2 
Formula weight 203.99 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Monoclinic 
Space group Cc 
a (Å) 9.9446(3) 
b (Å) 9.8158(3) 
c (Å) 13.6402(4) 
α (°) 90 
β (°) 100.1139(12) 
γ (°) 90 
Volume (Å3) 1310.79(7) 
Z 8 
Calculated density (Mg/m3) 2.979  
Absorption coefficient (mm-1) 10.400 
F(000) 1072 
Crystal size (mm) 0.15 x 0.12 x 0.12 
Theta range for data collection (°) 2.94 to 27.45 
Limiting indices -12 ≤ h ≤ 12, -12 ≤ k ≤ 12, -17 ≤ l ≤ 17 
Reflections collected 2775 
Unique reflections 2772 [R(int) = 0.0106] 
Completeness to theta = 27.45 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.3684 and 0.3045 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2772 / 2 / 110 
Goodness-of-fit on F2 1.022 
Final R indices [I>2σ(I)] R1 = 0.0228, wR2 = 0.0416 
R indices (all data) R1 = 0.0274, wR2 = 0.0429 
Extinction coefficient 0.00073(5) 
Largest diff. peak and hole .583 and -.559 e.A-3 
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Table A9. Bond lengths (Å) and angles (°) for 2-iodo-1,3,2-dithiarsolane (14) 
Atoms Bond lengths (Å) 
As(1A)-S(1A) 2.2119(19) 
As(1A)-S(2A) 2.2311(17) 
As(1A)-I(1A) 2.6502(7) 
S(1A)-C(1A) 1.817(5) 
S(2A)-C(2A) 1.825(5) 
C(1A)-C(2A) 1.522(6) 
C(1A)-H(1A1) 0.9900 
C(1A)-H(1A2) 0.9900 
C(2A)-H(2A1) 0.9900 
C(2A)-H(2A2) 0.9900 
As(1B)-S(2B) 2.2162(17) 
As(1B)-S(1B) 2.2312(19) 
As(1B)-I(1B) 2.6474(7) 
S(1B)-C(1B) 1.816(6) 
S(2B)-C(2B) 1.822(5) 
C(1B)-C(2B) 1.507(6) 
C(1B)-H(1B1) 0.9900 
C(1B)-H(1B2) 0.9900 
C(2B)-H(2B1) 0.9900 
C(2B)-H(2B2) 0.9900 
  
Atoms Bond angles (°) 
S(1A)-As(1A)-S(2A) 93.20(7) 
S(1A)-As(1A)-I(1A) 99.80(5) 
S(2A)-As(1A)-I(1A) 100.56(5) 
C(1A)-S(1A)-As(1A) 97.39(17) 
C(2A)-S(2A)-As(1A) 101.27(16) 
C(2A)-C(1A)-S(1A) 110.6(3) 
C(2A)-C(1A)-H(1A1) 109.5 
S(1A)-C(1A)-H(1A1) 109.5 
C(2A)-C(1A)-H(1A2) 109.5 
S(1A)-C(1A)-H(1A2) 109.5 
H(1A1)-C(1A)-H(1A2) 108.1 
C(1A)-C(2A)-S(2A) 112.2(3) 
C(1A)-C(2A)-H(2A1) 109.2 
S(2A)-C(2A)-H(2A1) 109.2 
C(1A)-C(2A)-H(2A2) 109.2 
S(2A)-C(2A)-H(2A2) 109.2 
H(2A1)-C(2A)-H(2A2) 107.9 
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S(2B)-As(1B)-S(1B) 93.23(7) 
S(2B)-As(1B)-I(1B) 99.65(5) 
S(1B)-As(1B)-I(1B) 100.80(5) 
C(1B)-S(1B)-As(1B) 101.26(18) 
C(2B)-S(2B)-As(1B) 97.15(18) 
C(2B)-C(1B)-S(1B) 112.4(3) 
C(2B)-C(1B)-H(1B1) 109.1 
S(1B)-C(1B)-H(1B1) 109.1 
C(2B)-C(1B)-H(1B2) 109.1 
S(1B)-C(1B)-H(1B2) 109.1 
H(1B1)-C(1B)-H(1B2) 107.9 
C(1B)-C(2B)-S(2B) 111.0(4) 
C(1B)-C(2B)-H(2B1) 109.4 
S(2B)-C(2B)-H(2B1) 109.4 
C(1B)-C(2B)-H(2B2) 109.4 
S(2B)-C(2B)-H(2B2) 109.4 
H(2B1)-C(2B)-H(2B2) 108.0 
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Figure A10. Packing diagram for 2-chloro-1,3,2-dithiarsenane (15). Hydrogen atoms are 
omitted for clarity. 
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Table A11. Crystal data and structure refinement for 2-chloro-1,3,2-dithiarsenane (15) 
Compound 2-chloro-1,3,2-dithiarsenane 
Empirical formula  C3H6AsClS2 
Formula weight 216.5 7 
Temperature (K) 90.0(2) K 
Wavelength (Å) 0.71073 
Crystal system Orthorhombic 
Space group Pnma 
a (Å) 9.9720(5) 
b (Å) 9.7510(4) 
c (Å) 7.0530(6) 
α (°) 90 
β (°) 90 
γ (°) 90 
Volume (Å3) 685.81(7) 
Z 4 
Calculated density (Mg/m3) 2.097 
Absorption coefficient (mm-1) 5.833 
F(000) 424 
Crystal size (mm) 0.15 x 0.15 x 0.05 
Theta range for data collection (°) 3.54 to 24.99 
Limiting indices -11 ≤ h ≤ 11,  -11 ≤ k ≤ 11, -7 ≤ l ≤ 8 
Reflections collected 2212 
Unique reflections 650 [R(int) = 0.0375] 
Completeness to theta = 24.99 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7591 and 0.4749 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 650 / 0 / 37 
Goodness-of-fit on F2 1.202 
Final R indices [I>2σ(I)] R1 = 0.0267, wR2 = 0.0621 
R indices (all data) R1 = 0.0293, wR2 = 0.0630 
Largest diff. peak and hole 0.452 and -0.750 e.A-3 
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Table A12. Bond lengths (Å) and angles (°) for 2-chloro-1,3,2-dithiarsenane (15) 
Atoms Bond lengths (Å) 
As(1)-S(1) 2.2188(9) 
As(1)-S(1)#1 2.2189(9) 
As(1)-Cl(1) 2.2328(13) 
S(1)-C(1) 1.830(4) 
C(1)-C(2) 1.518(4) 
C(1)-H(1A) 0.9900 
C(1)-H(1B) 0.9900 
C(2)-C(1)#1 1.518(4) 
C(2)-H(2A) 0.9900 
C(2)-H(2B) 0.9900 
 
Atoms Bond angles (°) 
S(1)-As(1)-S(1)#1 102.20(5) 
S(1)-As(1)-Cl(1) 98.32(3) 
S(1)#1-As(1)-Cl(1) 98.32(3) 
C(1)-S(1)-As(1) 104.28(12) 
C(2)-C(1)-S(1) 115.8(3) 
C(2)-C(1)-H(1A) 108.3 
S(1)-C(1)-H(1A) 108.3 
C(2)-C(1)-H(1B) 108.3 
S(1)-C(1)-H(1B) 108.3 
H(1A)-C(1)-H(1B) 107.4 
C(1)-C(2)-C(1)#1 115.4(4) 
C(1)-C(2)-H(2A) 108.4 
C(1)#1-C(2)-H(2A) 108.4 
C(1)-C(2)-H(2B) 108.4 
C(1)#1-C(2)-H(2B) 108.4 
H(2A)-C(2)-H(2B) 107.5 
Symmetry transformations used to generate equivalent atoms: #1 x,-y+1/2,z 
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Figure A13. Packing diagram for 2-bromo-1,3,2-dithiarsenane (16). Hydrogen atoms are 
omitted for clarity. 
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Table A14. Crystal data and structure refinement for 2-bromo-1,3,2-dithiarsenane (16) 
Compound 2-bromo-1,3,2-dithiarsenane 
Empirical formula  C3H6AsBrS2 
Formula weight 261.03 
Temperature (K) 90.0(2) K 
Wavelength (Å) 0.71073 
Crystal system Monoclinic 
Space group P21/c 
a (Å) 8.7723(1) 
b (Å) 6.8078(1) 
c (Å) 11.9217(2) 
α (°) 90 
β (°) 93.6077(6) 
γ (°) 90 
Volume (Å3) 710.554(18) 
Z 4 
Calculated density (Mg/m3) 2.440 
Absorption coefficient (mm-1) 10.877 
F(000) 496 
Crystal size (mm) 0.18 x 0.15 x 0.08 
Theta range for data collection (°) 2.33 to 27.47 
Limiting indices -11 ≤ h ≤ 11,  -8 ≤ k ≤ 8, -15 ≤ l ≤ 15 
Reflections collected 3133 
Unique reflections 1636 [R(int) = 0.0146] 
Completeness to theta = 24.99 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.4765 and 0.2449 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1636 / 0 / 65 
Goodness-of-fit on F2 1.077 
Final R indices [I>2σ(I)] R1 = 0.0149, wR2 = 0.0341 
R indices (all data) R1 = 0.0164, wR2 = 0.0347 
Extinction coefficient 0.0079(3) 
Largest diff. peak and hole 0.334 and -0.375 e.A-3 
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Table A15. Bond lengths (Å) and angles (°) for 2-bromo-1,3,2-dithiarsenane (16) 
Atoms Bond lengths (Å) 
As(1)-S(1) 2.2226(5) 
As(1)-S(2) 2.2284(5) 
As(1)-Br(1) 2.3901(2) 
S(1)-C(1) 1.8247(18) 
S(2)-C(3) 1.8237(18) 
C(1)-C(2) 1.519(2) 
C(1)-H(1A) 0.9900 
C(1)-H(1B) 0.9900 
C(2)-C(3) 1.525(2) 
C(2)-H(2A) 0.9900 
C(2)-H(2B) 0.9900 
C(3)-H(3A) 0.9900 
C(3)-H(3B) 0.9900 
 
Atoms Bond angles (°) 
S(1)-As(1)-S(2)  100.595(17) 
S(1)-As(1)-Br(1) 99.199(14) 
S(2)-As(1)-Br(1) 99.612(14) 
C(1)-S(1)-As(1) 105.27(6) 
C(3)-S(2)-As(1) 104.45(6) 
C(2)-C(1)-S(1) 116.01(12) 
C(2)-C(1)-H(1A) 108.3 
S(1)-C(1)-H(1A) 108.3 
C(2)-C(1)-H(1B) 108.3 
S(1)-C(1)-H(1B) 108.3 
H(1A)-C(1)-H(1B) 107.4 
C(1)-C(2)-C(3) 114.38(14) 
C(1)-C(2)-H(2A) 108.7 
C(3)-C(2)-H(2A) 108.7 
C(1)-C(2)-H(2B) 108.7 
C(3)-C(2)-H(2B) 108.7 
H(2A)-C(2)-H(2B) 107.6 
C(2)-C(3)-S(2) 115.50(13) 
C(2)-C(3)-H(3A) 108.4 
S(2)-C(3)-H(3A) 108.4 
C(2)-C(3)-H(3B) 108.4 
S(2)-C(3)-H(3B) 108.4 
H(3A)-C(3)-H(3B) 107.5 
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Figure A16. Packing diagram for 2-iodo-1,3,2-dithiarsenane (17). Hydrogen atoms are 
omitted for clarity. 
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Table A17. Crystal data and structure refinement for 2-iodo-1,3,2-dithiarsenane (17) 
Compound 2-iodo-1,3,2-dithiarsenane 
Empirical formula  C3H6AsIS2 
Formula weight 308.02 
Temperature (K) 90.0(2) K 
Wavelength (Å) 0.71073 
Crystal system Monoclinic 
Space group P21/n 
a (Å) 7.3970(2) 
b (Å) 12.9494(3) 
c (Å) 8.0262(2) 
α (°) 90 
β (°) 101.1213(10) 
γ (°) 90 
Volume (Å3) 754.37(3) 
Z 4 
Calculated density (Mg/m3) 2.712 
Absorption coefficient (mm-1) 9.042 
F(000) 568 
Crystal size (mm) 0.15 x 0.14 x 0.10 
Theta range for data collection (°) 3.03 to 27.49 
Limiting indices -9 ≤ h ≤ 9, -16 ≤ k ≤ 16, -10 ≤ l ≤ 10 
Reflections collected 3386 
Unique reflections 1735 [R(int) = 0.0200] 
Completeness to theta = 27.49 99.9 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.4650 and 0.3441 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1735 / 0 / 68 
Goodness-of-fit on F2 1.076 
Final R indices [I>2σ(I)] R1 = 0.0186, wR2 = 0.0383 
R indices (all data) R1 = 0.0232, wR2 = 0.0397 
Extinction coefficient 0.0034(2) 
Largest diff. peak and hole .717 and -.704 e.A-3 
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Table A18. Bond lengths (Å) and angles (°) for 2-iodo-1,3,2-dithiarsenane (17) 
Atoms Bond lengths (Å) 
I(1)-As(1) 2.6036(3) 
As(1)-S(2) 2.2215(7) 
As(1)-S(1) 2.2252(7) 
S(1)-C(1) 1.823(3) 
S(2)-C(3) 1.828(3) 
C(3)-C(2) 1.519(3) 
C(3)-H(3A) 0.9697 
C(3)-H(3B) 0.9697 
C(1)-C(2) 1.517(4) 
C(1)-H(1A) 0.9762 
C(1)-H(1B) 0.9762 
C(2)-H(2A) 0.9943 
C(2)-H(2B) 0.9943 
 
Atoms Bond angles (°) 
S(2)-As(1)-S(1) 101.42(3) 
S(2)-As(1)-I(1) 100.624(19) 
S(1)-As(1)-I(1) 100.87(2) 
C(1)-S(1)-As(1) 105.42(9) 
C(3)-S(2)-As(1) 104.69(9) 
C(2)-C(3)-S(2) 116.70(19) 
C(2)-C(3)-H(3A) 108.1 
S(2)-C(3)-H(3A) 108.1 
C(2)-C(3)-H(3B) 108.1 
S(2)-C(3)-H(3B) 108.1 
H(3A)-C(3)-H(3B) 107.3 
C(2)-C(1)-S(1) 115.42(19) 
C(2)-C(1)-H(1A) 108.4 
S(1)-C(1)-H(1A) 108.4 
C(2)-C(1)-H(1B) 108.4 
S(1)-C(1)-H(1B)   108.4 
H(1A)-C(1)-H(1B) 107.5 
C(1)-C(2)-C(3) 115.2(2) 
C(1)-C(2)-H(2A) 108.5 
C(3)-C(2)-H(2A) 108.5 
C(1)-C(2)-H(2B)   108.5 
C(3)-C(2)-H(2B) 108.5 
H(2A)-C(2)-H(2B) 107.5 
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Figure A19. Packing diagram for 3-chloro-4H,7H-5,6-benz-1,3,2-dithiarsepine (18). 
Hydrogen atoms are omitted for clarity. 
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Table A20. Crystal data and structure refinement for 3-chloro-4H,7H-5,6-benz-1,3,2-
dithiarsepine (18) 
Compound 3-chloro-4H,7H-5,6-benz-1,3,2-
dithiarsepine 
Empirical formula  C8H8AsClS2 
Formula weight 278.63 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Orthorhombic 
Space group Pnma 
a (Å) 9.5439(3) 
b (Å) 9.9009(3) 
c (Å) 10.4746(3) 
α (°) 90 
β (°) 90 
γ (°) 90 
Volume (Å3) 989.78(5) 
Z 4 
Calculated density (Mg/m3) 1.870 
Absorption coefficient (mm-1) 4.065 
F(000) 552 
Crystal size (mm) 0.15 x 0.15 x 0.15 
Theta range for data collection (°) 2.83 to 27.48 
Limiting indices -12<=h<=12, -12<=k<=12, -13<=l<=13 
Reflections collected 2155 
Unique reflections 1208 [R(int) = 0.0230] 
Completeness to theta = 27.48 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5807 and 0.5807 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1208 / 0 / 59 
Goodness-of-fit on F2 1.099 
Final R indices [I>2σ(I)] R1 = 0.0231, wR2 = 0.0503 
R indices (all data) R1 = 0.0321, wR2 = 0.0530 
Extinction coefficient 0.0032(5) 
Largest diff. peak and hole .434 and -.405 e.A-3 
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Table A21. Bond lengths (Å) and angles (°) for 3-chloro-4H,7H-5,6-benz-1,3,2-
dithiarsepine (18) 
Atoms Bond lengths (Å) 
As(1)-S(1)#1 2.2316(5) 
As(1)-S(1) 2.2317(5) 
As(1)-Cl(1) 2.2351(8) 
S(1)-C(1) 1.8325(19) 
C(1)-C(2) 1.507(3) 
C(1)-H(1A) 0.9900 
C(1)-H(1B) 0.9900 
C(2)-C(3) 1.396(3) 
C(2)-C(2)#1 1.406(4) 
C(3)-C(4) 1.389(3) 
C(3)-H(3) 0.9500 
C(4)-C(4)#1 1.382(4) 
C(4)-H(4) 0.9500 
                                                                    
Atoms Bond angles (°) 
S(1)#1-As(1)-S(1) 105.06(3) 
S(1)#1-As(1)-Cl(1) 97.842(19) 
S(1)-As(1)-Cl(1) 97.842(19) 
C(1)-S(1)-As(1) 108.01(7) 
C(2)-C(1)-S(1) 113.39(13) 
C(2)-C(1)-H(1A) 108.9 
S(1)-C(1)-H(1A) 108.9 
C(2)-C(1)-H(1B) 108.9 
S(1)-C(1)-H(1B) 108.9 
H(1A)-C(1)-H(1B) 107.7 
C(3)-C(2)-C(2)#1 119.26(12) 
C(3)-C(2)-C(1) 118.85(17) 
C(2)#1-C(2)-C(1) 121.87(11) 
C(4)-C(3)-C(2) 120.75(19) 
C(4)-C(3)-H(3) 119.6 
C(2)-C(3)-H(3) 119.6 
C(4)#1-C(4)-C(3) 119.97(12) 
C(4)#1-C(4)-H(4) 120.0 
C(3)-C(4)-H(4) 120.0 
Symmetry transformations used to generate equivalent atoms: #1 x,-y+1/2,z 
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Figure A22. Packing diagram for 2-chloro-benzo-1,3,2-dithiarsole (19). Hydrogen atoms 
are omitted for clarity. 
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Table A23. Crystal data and structure refinement for 2-chloro-benzo-1,3,2-dithiarsole 
(19). However, the refinement can not be completed. 
Compound 2-chloro-benzo-1,3,2-dithiarsole 
Empirical formula  C6H4AsClS2 
Formula weight 250.60 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Triclinic 
Space group 
P
_
1  
a (Å) 12.3533(2) 
b (Å) 22.3789(3) 
c (Å) 26.6255(5) 
α (°) 76.7415(7) 
β (°) 80.0542(8) 
γ (°) 76.8076(7) 
Volume (Å3) 6918.93 
Z 34 
Calculated density (Mg/m3) 2.045 
Absorption coefficient (mm-1)  
F(000) 4148 
Crystal size (mm)  
Theta range for data collection (°)  
Limiting indices -14 ≤ h ≤14, -26 ≤ k ≤ 26, -31 ≤ l ≤ 31 
Reflections collected 24396 
Unique reflections 8774 [R(int) = 0.0804] 
Completeness to theta = 25.00  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 24396/4590/1531 
Goodness-of-fit on F2 0.922 
Final R indices [I>2σ(I)] R1 = 0.0367, wR2 = 0.0706 
R indices (all data) R1 = 0.1351, wR2 = 0.0961 
Absolute structure parameter  
Largest diff. peak and hole 0..494 and -.675 e.A-3 
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Table A24. Bond lengths (Å) and angles (°) for 2-chloro-benzo-1,3,2-dithiarsole (19) The 
bond lengths are averaged across the unsymmetrical unit. The bond angles were taken 
from a representative molecule (J).  
Atoms Bond lengths (Å) 
As(1)-S(1) 2.209471 
As(1)-S(2) 2.209765 
As(1)-Cl(1) 2.290294 
S(1)-C(1) 1.756059 
S(2)-C(6) 1.771059 
C(1)-C(2) 1.391529 
C(2)-C(3) 1.378176 
C(3)-C(4) 1.386235 
C(4)-C(5) 1.376529 
C(5)-C(6) 1.394588 
C(1)-C(6) 1.396353 
C(2)-H(2) 0.950235 
C(3)-H(3) 0.950176 
C(4)-H(4) 0.9500 
C(5)-H(5) 0.949824 
                            
Atoms Bond angles (°) 
S(1)-As(1)-S(2) 93.52 
S(1)-As(1)-Cl(1) 100.25 
S(2)-As(1)-Cl(1) 99.68 
C(6)-S(2)-As(1) 101.12 
C(1)-S(1)-As(1) 101.48 
C(5)-C(6)-S(2) 119.16 
C(2)-C(1)-S(1) 118.48 
S(2)-C(6)-C(1) 120.61 
S(1)-C(1)-C(6) 121.65 
C(1)-C(2)-C(3) 119.45 
C(2)-C(3)-C(4) 120.29 
C(3)-C(4)-C(5) 121.13 
C(4)-C(5)-C(6) 118.94 
C(5)-C(6)-C(1) 120.20 
C(6)-C(1)-C(2) 119.75 
C(1)-C(2)-H(2) 120.19 
C(2)-C(3)-H(3) 119.71 
C(3)-C(4)-H(4) 119.45 
119 
C(4)-C(5)-H(5) 120.49 
H(2)-C(2)-C(3) 120.36 
H(3)-C(3)-C(4) 120.01 
H(4)-C(4)-C(5) 119.42 
H(5)-C(5)-C(6) 120.57 
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Figure A25. Packing diagram for 1,2-bis-dithiarsolan-2-ylmercapto-ethane (20). 
Hydrogen atoms are omitted for clarity. 
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Table A26. Crystal data and structure refinement for 1,2-bis-dithiarsolan-2-ylmercapto-
ethane (20) 
Compound 1,2-bis-dithiarsolan-2-ylmercapto-ethane 
Empirical formula  C3H6AsS3 
Formula weight 213.18 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Orthorhombic 
Space group P212121 
a (Å) 5.0916(1) 
b (Å) 10.2877(3) 
c (Å) 26.2326(8) 
α (°) 90 
β (°) 90 
γ (°) 90 
Volume (Å3) 1374.09(6) 
Z 8 
Calculated density (Mg/m3) 2.061 
Absorption coefficient (mm-1) 5.737 
F(000) 840 
Crystal size (mm) 0.28 x 0.08 x 0.01 
Theta range for data collection (°) 1.55 to 25.34 
Limiting indices -6 ≤ h ≤ 6, -12 ≤ k ≤ 12, -31 ≤ l ≤ 31 
Reflections collected 2514 
Unique reflections 2514 [R(int) = 0.0890] 
Completeness to theta = 25.34 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9449 and 0.2965 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2514 / 0 / 127 
Goodness-of-fit on F2 0.983 
Final R indices [I>2σ(I)] R1 = 0.0368, wR2 = 0.0701 
R indices (all data) R1 = 0.0566, wR2 = 0.0762 
Absolute structure parameter -0.005(14) 
Largest diff. peak and hole .675 and -.522 e.A-3 
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Table A27. Bond lengths (Å) and angles (°) for 1,2-bis-dithiarsolan-2-ylmercapto-ethane 
(20) 
Atoms Bond lengths (Å) 
As(1)-S(1) 2.2315(17) 
As(1)-S(2) 2.2472(16) 
As(1)-S(3) 2.2610(17) 
As(2)-S(5) 2.2311(16) 
As(2)-S(6) 2.2452(16) 
As(2)-S(4) 2.2683(16) 
S(1)-C(1) 1.810(6) 
S(2)-C(2) 1.835(6) 
S(3)-C(3) 1.838(6) 
S(4)-C(4) 1.817(5) 
S(5)-C(5) 1.820(6) 
S(6)-C(6) 1.832(6) 
C(1)-C(2) 1.509(7) 
C(1)-H(1A) 0.9900 
C(1)-H(1B) 0.9900 
C(2)-H(2A) 0.9900 
C(2)-H(2B) 0.9900 
C(3)-C(4) 1.510(8) 
C(3)-H(3A) 0.9900 
C(3)-H(3B) 0.9900 
C(4)-H(4A) 0.9900 
C(4)-H(4B) 0.9900 
C(5)-C(6) 1.518(8) 
C(5)-H(5A) 0.9900 
C(5)-H(5B) 0.9900 
C(6)-H(6A) 0.9900 
C(6)-H(6B) 0.9900 
                            
Atoms Bond angles (°) 
S(1)-As(1)-S(2) 93.24(6) 
S(1)-As(1)-S(3) 102.15(6) 
S(2)-As(1)-S(3) 94.33(6) 
S(5)-As(2)-S(6) 93.86(6) 
S(5)-As(2)-S(4) 99.46(6) 
S(6)-As(2)-S(4) 93.21(6) 
C(1)-S(1)-As(1) 95.77(19) 
C(2)-S(2)-As(1) 100.3(2) 
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C(3)-S(3)-As(1) 97.5(2) 
C(4)-S(4)-As(2) 97.52(19) 
C(5)-S(5)-As(2) 95.8(2) 
C(6)-S(6)-As(2) 99.6(2) 
C(2)-C(1)-S(1) 110.9(4) 
C(2)-C(1)-H(1A) 109.5 
S(1)-C(1)-H(1A) 109.5 
C(2)-C(1)-H(1B) 109.5 
S(1)-C(1)-H(1B) 109.5 
H(1A)-C(1)-H(1B) 108.1 
C(1)-C(2)-S(2) 110.9(4) 
C(1)-C(2)-H(2A) 109.5 
S(2)-C(2)-H(2A) 109.5 
C(1)-C(2)-H(2B) 109.5 
S(2)-C(2)-H(2B) 109.5 
H(2A)-C(2)-H(2B) 108.0 
C(4)-C(3)-S(3) 113.0(4) 
C(4)-C(3)-H(3A) 109.0 
S(3)-C(3)-H(3A) 109.0 
C(4)-C(3)-H(3B) 109.0 
S(3)-C(3)-H(3B) 109.0 
H(3A)-C(3)-H(3B) 107.8 
C(3)-C(4)-S(4) 112.8(4) 
C(3)-C(4)-H(4A) 109.0 
S(4)-C(4)-H(4A) 109.0 
C(3)-C(4)-H(4B) 109.0 
S(4)-C(4)-H(4B) 109.0 
H(4A)-C(4)-H(4B) 107.8 
C(6)-C(5)-S(5) 109.9(4) 
C(6)-C(5)-H(5A) 109.7 
S(5)-C(5)-H(5A) 109.7 
C(6)-C(5)-H(5B) 109.7 
S(5)-C(5)-H(5B) 109.7 
H(5A)-C(5)-H(5B) 108.2 
C(5)-C(6)-S(6) 112.4(4) 
C(5)-C(6)-H(6A) 109.1 
S(6)-C(6)-H(6A) 109.1 
C(5)-C(6)-H(6B) 109.1 
S(6)-C(6)-H(6B) 109.1 
H(6A)-C(6)-H(6B) 107.9 
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Figure A28. Packing diagram for tris-(pentafluorophenylthio)-arsen (21). 
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Table A29. Crystal data and structure refinement for tris-(pentafluorophenylthio)-arsen 
(21) 
Compound tris-(pentafluorophenylthio)-arsen 
Empirical formula  C18AsF15S3 
Formula weight 672.28 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Orthorhombic 
Space group Fdd2 
a (Å) 32.5222(1) 
b (Å) 46.8717(4) 
c (Å) 5.5499(6) 
α (°) 90 
β (°) 90 
γ (°) 90 
Volume (Å3) 8460.1(9) 
Z 16 
Calculated density (Mg/m3) 2.111 
Absorption coefficient (mm-1) 2.042 
F(000) 5184 
Crystal size (mm) 0.25 x 0.10 x 0.08 
Theta range for data collection (°) 1.52 to 27.50 
Limiting indices -41 ≤ h ≤ 42, -59 ≤ k ≤ 60, -7 ≤ l ≤ 7 
Reflections collected 4794 
Unique reflections 4794 [R(int) = 0.079] 
Completeness to theta = 27.50 100.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8619 and 0.6293 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4794 / 1 / 335 
Goodness-of-fit on F2 1.028 
Final R indices [I>2σ(I)] R1 = 0.0349, wR2 = 0.0853 
R indices (all data) R1 = 0.0457, wR2 = 0.0906 
Absolute structure parameter 0.455(9) 
Largest diff. peak and hole .675 and -.547 e.A-3 
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Table A30. Bond lengths (Å) and angles (°) for tris-(pentafluorophenylthio)-arsen (21) 
Atoms Bond lengths (Å) 
As(1)-S(3) 2.2585(10) 
As(1)-S(2) 2.2622(11) 
As(1)-S(1) 2.2660(10) 
S(1)-C(1) 1.767(4) 
S(2)-C(7) 1.771(4) 
S(3)-C(13) 1.751(4) 
C(1)-C(6) 1.370(6) 
C(1)-C(2) 1.397(5) 
C(2)-F(1) 1.336(5) 
C(2)-C(3) 1.381(5) 
C(3)-F(2) 1.345(4) 
C(3)-C(4) 1.366(6) 
C(4)-F(3) 1.335(5) 
C(4)-C(5) 1.382(5) 
C(5)-F(4) 1.350(5) 
C(5)-C(6) 1.367(6) 
C(6)-F(5) 1.349(4) 
C(7)-C(8) 1.379(6) 
C(7)-C(12) 1.380(6) 
C(8)-F(6) 1.333(4) 
C(8)-C(9) 1.382(5) 
C(9)-F(7) 1.341(5) 
C(9)-C(10) 1.369(6) 
C(10)-F(8) 1.332(5) 
C(10)-C(11) 1.385(7) 
C(11)-F(9) 1.341(5) 
C(11)-C(12) 1.371(7) 
C(12)-F(10) 1.333(5) 
C(13)-C(14) 1.391(5) 
C(13)-C(18) 1.399(5) 
C(14)-F(11) 1.335(5) 
C(14)-C(15) 1.378(7) 
C(15)-F(12) 1.342(5) 
C(15)-C(16) 1.363(6) 
C(16)-F(13) 1.342(5) 
C(16)-C(17) 1.364(6) 
C(17)-F(14) 1.333(5) 
C(17)-C(18) 1.381(6) 
C(18)-F(15) 1.334(4) 
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Atoms Bond angles (°) 
S(3)-As(1)-S(2) 98.53(4) 
S(3)-As(1)-S(1) 98.31(4) 
S(2)-As(1)-S(1) 87.82(4) 
C(1)-S(1)-As(1) 96.93(13) 
C(7)-S(2)-As(1) 97.66(13) 
C(13)-S(3)-As(1) 100.52(13) 
C(6)-C(1)-C(2) 117.1(4) 
C(6)-C(1)-S(1) 122.3(3) 
C(2)-C(1)-S(1) 120.6(3) 
F(1)-C(2)-C(3) 118.0(3) 
F(1)-C(2)-C(1) 120.8(4) 
C(3)-C(2)-C(1) 121.2(4) 
F(2)-C(3)-C(4) 119.6(4) 
F(2)-C(3)-C(2) 120.3(4) 
C(4)-C(3)-C(2) 120.1(4) 
F(3)-C(4)-C(3) 120.3(4) 
F(3)-C(4)-C(5) 120.3(4) 
C(3)-C(4)-C(5) 119.4(4) 
F(4)-C(5)-C(6) 121.0(3) 
F(4)-C(5)-C(4) 119.1(3) 
C(6)-C(5)-C(4) 120.0(4) 
F(5)-C(6)-C(5) 117.8(4) 
F(5)-C(6)-C(1) 120.0(4) 
C(5)-C(6)-C(1) 122.3(4) 
C(8)-C(7)-C(12) 117.6(4) 
C(8)-C(7)-S(2) 121.4(3) 
C(12)-C(7)-S(2) 120.9(3) 
F(6)-C(8)-C(7) 120.9(3) 
F(6)-C(8)-C(9) 117.8(4) 
C(7)-C(8)-C(9) 121.3(4) 
F(7)-C(9)-C(10) 119.4(4) 
F(7)-C(9)-C(8) 120.3(4) 
C(10)-C(9)-C(8) 120.3(4) 
F(8)-C(10)-C(9) 120.5(4) 
F(8)-C(10)-C(11) 120.4(4) 
C(9)-C(10)-C(11) 119.1(4) 
F(9)-C(11)-C(12) 120.3(5) 
F(9)-C(11)-C(10) 119.7(4) 
C(12)-C(11)-C(10) 120.0(4) 
F(10)-C(12)-C(11) 118.5(4) 
F(10)-C(12)-C(7) 119.8(4) 
C(11)-C(12)-C(7) 121.7(4) 
C(14)-C(13)-C(18) 115.9(4) 
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C(14)-C(13)-S(3) 121.6(3) 
C(18)-C(13)-S(3) 122.3(3) 
F(11)-C(14)-C(15) 118.4(4) 
F(11)-C(14)-C(13) 119.3(4) 
C(15)-C(14)-C(13) 122.3(4) 
F(12)-C(15)-C(16) 120.7(4) 
F(12)-C(15)-C(14) 119.7(4) 
C(16)-C(15)-C(14) 119.7(4) 
F(13)-C(16)-C(15) 120.0(4) 
F(13)-C(16)-C(17) 119.3(4) 
C(15)-C(16)-C(17) 120.5(4) 
F(14)-C(17)-C(16) 120.0(4) 
F(14)-C(17)-C(18) 120.2(4) 
C(16)-C(17)-C(18) 119.7(4) 
F(15)-C(18)-C(17) 118.9(4) 
F(15)-C(18)-C(13) 119.3(4) 
C(17)-C(18)-C(13) 121.8(4) 
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Figure A31. Packing diagram for bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)-
benzenesulfide) (22). Hydrogen atoms are omitted for clarity. 
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Table A32. Crystal data and structure refinement for bis(2-(1,3,2-benzodithiarsol-
2ylsulfanyl)-benzenesulfide) (22) 
Compound bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)-
benzenesulfide) 
Empirical formula  C24H16As2S8 
Formula weight 710.69 
Temperature (K) 90.0(2) 
Wavelength (Å) 1.54178 
Crystal system Monoclinic 
Space group C2/c 
a (Å) 24.3415(4) 
b (Å) 12.8324(2) 
c (Å) 8.7729(2) 
α (°) 90 
β (°) 109.440(1) 
γ (°) 90 
Volume (Å3) 2584.08(8) 
Z 4 
Calculated density (Mg/m3) 1.827 
Absorption coefficient (mm-1) 9.366 
F(000) 1416 
Crystal size (mm) 0.09 x 0.04 x 0.01 
Theta range for data collection (°) 3.85 to 68.04 
Limiting indices -29 ≤ h ≤ 29, -15 ≤ k ≤ 15, -7 ≤ l ≤ 10 
Reflections collected 16482 
Unique reflections 2327 [R(int) = 0.0472] 
Completeness to theta = 68.04 98.3 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.912 and 0.699 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2327 / 0 / 154 
Goodness-of-fit on F2 1.054 
Final R indices [I>2σ(I)] R1 = 0.0265, wR2 = 0.0662 
R indices (all data) R1 = 0.0319, wR2 = 0.0691 
Largest diff. peak and hole .356 and -.482 e.A-3 
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Table A33. Bond lengths (Å) and angles (°) for bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)-
benzenesulfide) (22) 
Atoms Bond lengths (Å) 
As(1)-S(2) 2.2331(6) 
As(1)-S(1) 2.2465(7) 
As(1)-S(3) 2.2930(7) 
S(1)-C(1) 1.765(3) 
S(2)-C(2) 1.769(3) 
S(3)-C(7) 1.774(3) 
S(4)-C(12) 1.791(2) 
S(4)-S(4)#1 2.0511(12) 
C(1)-C(6) 1.396(4) 
C(1)-C(2) 1.398(4) 
C(2)-C(3)  1.395(4) 
C(3)-C(4) 1.386(4) 
C(3)-H(3) 0.9500 
C(4)-C(5) 1.384(4) 
C(4)-H(4) 0.9500 
C(5)-C(6) 1.384(4) 
C(5)-H(5) 0.9500 
C(6)-H(6) 0.9500 
C(7)-C(8) 1.395(4) 
C(7)-C(12) 1.403(4) 
C(8)-C(9) 1.390(4) 
C(8)-H(8) 0.9500 
C(9)-C(10) 1.384(4) 
C(9)-H(9) 0.9500 
C(10)-C(11) 1.392(4) 
C(10)-H(10) 0.9500 
C(11)-C(12) 1.389(4) 
C(11)-H(11) 0.9500 
  
Atoms Bond angles (°) 
S(2)-As(1)-S(1) 91.86(2) 
S(2)-As(1)-S(3) 103.61(2) 
S(1)-As(1)-S(3) 102.99(3) 
C(1)-S(1)-As(1) 101.30(9) 
C(2)-S(2)-As(1) 101.32(9) 
C(7)-S(3)-As(1) 103.75(8) 
132 
C(12)-S(4)-S(4)#1 104.03(9) 
C(6)-C(1)-C(2) 120.0(2) 
C(6)-C(1)-S(1) 118.9(2) 
C(2)-C(1)-S(1) 121.0(2) 
C(3)-C(2)-C(1) 119.7(2) 
C(3)-C(2)-S(2) 119.3(2) 
C(1)-C(2)-S(2) 121.0(2) 
C(4)-C(3)-C(2) 119.6(3) 
C(4)-C(3)-H(3) 120.2 
C(2)-C(3)-H(3) 120.2 
C(5)-C(4)-C(3) 120.8(3) 
C(5)-C(4)-H(4) 119.6 
C(3)-C(4)-H(4) 119.6 
C(6)-C(5)-C(4) 120.0(2) 
C(6)-C(5)-H(5) 120.0 
C(4)-C(5)-H(5) 120.0 
C(5)-C(6)-C(1) 119.8(2) 
C(5)-C(6)-H(6) 120.1 
C(1)-C(6)-H(6) 120.1 
C(8)-C(7)-C(12) 119.3(2) 
C(8)-C(7)-S(3) 120.8(2) 
C(12)-C(7)-S(3) 119.89(19) 
C(9)-C(8)-C(7) 120.4(2) 
C(9)-C(8)-H(8) 119.8 
C(7)-C(8)-H(8) 119.8 
C(10)-C(9)-C(8) 119.7(2) 
C(10)-C(9)-H(9) 120.1 
C(8)-C(9)-H(9) 120.1 
C(9)-C(10)-C(11) 120.7(3) 
C(9)-C(10)-H(10) 119.7 
C(11)-C(10)-H(10) 119.7 
C(12)-C(11)-C(10) 119.7(2) 
C(12)-C(11)-H(11) 120.2 
C(10)-C(11)-H(11) 120.2 
C(11)-C(12)-C(7) 120.1(2) 
C(11)-C(12)-S(4) 123.35(19) 
C(7)-C(12)-S(4) 116.57(19) 
Symmetry transformations used to generate equivalent atoms: #1 -x+1,y,-z-1/2 
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Figure A34. Packing diagram for 2-chloro-benzo-1,3,2-dithiastibole (26). Hydrogen 
atoms are omitted for clarity. 
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Table A35. Crystal data and structure refinement for 2-chloro-benzo-1,3,2-dithiastibole 
(26) 
Compound 2-chloro-benzo-1,3,2-dithiastibole 
Empirical formula  C6H4ClS2Sb 
Formula weight 297.41 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Orthorhombic 
Space group Pbca 
a (Å) 8.8985(6) 
b (Å) 10.0884(8) 
c (Å) 18.7374(15) 
α (°) 90 
β (°) 90 
γ (°) 90 
Volume (Å3) 1682.1(2) 
Z 8 
Calculated density (Mg/m3) 2.349 
Absorption coefficient (mm-1) 4.011 
F(000) 1120 
Crystal size (mm) 0.20 x 0.10 x 0.10 
Theta range for data collection (°) 3.16 to 27.49 
Limiting indices -11 ≤ h ≤ 8, -13 ≤ k ≤ 12, -24 ≤ l ≤ 23 
Reflections collected 12586 
Unique reflections 1928 [R(int) = 0.0419] 
Completeness to theta = 27.49 99.9 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.6898 and 0.5592 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1928 / 0 / 92 
Goodness-of-fit on F2 1.112 
Final R indices [I>2σ(I)] R1 = 0.0284, wR2 = 0.0620 
R indices (all data) R1 = 0.0429, wR2 = 0.0685 
Extinction coefficient 0.00200(16) 
Largest diff. peak and hole 1.252 and -.870 e.A-3 
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Table A36. Bond lengths (Å) and angles (°) for 2-chloro-benzo-1,3,2-dithiastibole (26) 
Atoms Bond lengths (Å) 
Sb(1)-S(2) 2.4037(10) 
Sb(1)-S(1) 2.4118(9) 
Sb(1)-Cl(1) 2.4563(9) 
S(1)-C(1) 1.774(4) 
S(2)-C(6) 1.768(4) 
C(1)-C(6) 1.389(5) 
C(1)-C(2) 1.401(5) 
C(2)-C(3) 1.392(6) 
C(2)-H(2) 0.9500 
C(3)-C(4) 1.387(6) 
C(3)-H(3) 0.9500 
C(4)-C(5) 1.384(6) 
C(4)-H(4) 0.9500 
C(5)-C(6) 1.400(5) 
C(5)-H(5) 0.9500 
                            
Atoms Bond angles (°) 
S(2)-Sb(1)-S(1) 88.39(3) 
S(2)-Sb(1)-Cl(1) 93.41(3) 
S(1)-Sb(1)-Cl(1) 93.84(3) 
C(1)-S(1)-Sb(1) 100.50(13) 
C(6)-S(2)-Sb(1) 100.69(13) 
C(6)-C(1)-C(2) 119.7(4) 
C(6)-C(1)-S(1) 123.7(3) 
C(2)-C(1)-S(1) 116.6(3) 
C(3)-C(2)-C(1) 120.1(4) 
C(3)-C(2)-H(2) 120.0 
C(1)-C(2)-H(2) 120.0 
C(4)-C(3)-C(2) 120.3(4) 
C(4)-C(3)-H(3) 119.8 
C(2)-C(3)-H(3) 119.8 
C(5)-C(4)-C(3) 119.5(4) 
C(5)-C(4)-H(4) 120.2 
C(3)-C(4)-H(4) 120.2 
C(4)-C(5)-C(6) 120.9(4) 
C(4)-C(5)-H(5) 119.5 
C(6)-C(5)-H(5) 119.5 
C(1)-C(6)-C(5) 119.5(3) 
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C(1)-C(6)-S(2) 123.8(3) 
C(5)-C(6)-S(2) 116.7(3) 
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Figure A37. Molecular structure for 1,2-benzenedithiol. 
 
138 
 
Figure A38. Packing diagram for 1,2-benzenedithiol. Hydrogen atoms are omitted for 
clarity. 
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Table A39. Crystal data and structure refinement for 1,2-benzenedithiol 
Compound 1,2-benzendithiol 
Empirical formula  C6H6S2 
Formula weight 142.23 
Temperature (K) 90.0(2) 
Wavelength (Å) 0.71073 
Crystal system Triclinic 
Space group P-1 
a (Å) 7.6005(1) 
b (Å) 10.0250(2) 
c (Å) 10.0395(2) 
α (°) 95.5119(8) 
β (°) 111.1513(9) 
γ (°) 108.9276(9) 
Volume (Å3) 654.87(2) 
Z 4 
Calculated density (Mg/m3) 1.443 
Absorption coefficient (mm-1) 0.694 
F(000) 296 
Crystal size (mm) 0.20 x 0.10 x 0.05 
Theta range for data collection (°) 2.21 to 27.46 
Limiting indices -9<=h<=9, -12<=k<=13, -12<=l<=12 
Reflections collected 5777 
Unique reflections 2977 [R(int) = 0.0254] 
Completeness to theta = 27.46 99.7 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9661 and 0.8736 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2977 / 0 / 161 
Goodness-of-fit on F2 1.084 
Final R indices [I>2σ(I)] R1 = 0.0313, wR2 = 0.0749 
R indices (all data) R1 = 0.0450, wR2 = 0.0806 
Largest diff. peak and hole .346 and -.296 e.A-3 
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Table A40. Bond lengths (Å) and angles (°) for 1,2-benzenedithiol 
Atoms Bond lengths (Å) 
S(1A)-C(1A) 1.7704(17) 
S(1A)-H(1SA) 1.23(2) 
S(2A)-C(2A) 1.7697(17) 
S(2A)-H(2SA) 1.23(2) 
C(1A)-C(6A) 1.393(2) 
C(1A)-C(2A) 1.399(2) 
C(2A)-C(3A) 1.397(2) 
C(3A)-C(4A) 1.389(3) 
C(3A)-H(3A) 0.9500 
C(4A)-C(5A) 1.384(3) 
C(4A)-H(4A) 0.9500 
C(5A)-C(6A) 1.392(3) 
C(5A)-H(5A) 0.9500 
C(6A)-H(6A) 0.9500 
S(1B)-C(1B) 1.7738(17) 
S(1B)-H(1SB) 1.25(2) 
S(2B)-C(2B) 1.7678(17) 
S(2B)-H(2SB) 1.25(2) 
C(1B)-C(3B) 1.394(2) 
C(1B)-C(2B) 1.399(2) 
C(2B)-C(6B) 1.397(2) 
C(3B)-C(4B) 1.382(2) 
C(3B)-H(3B) 0.9500 
C(4B)-C(5B) 1.391(2) 
C(4B)-H(4B) 0.9500 
C(5B)-C(6B) 1.383(2) 
C(5B)-H(5B) 0.9500 
C(6B)-H(6B) 0.9500 
           
Atoms Bond angles (°) 
C(1A)-S(1A)-H(1SA) 96.6(11) 
C(2A)-S(2A)-H(2SA) 96.0(10) 
C(6A)-C(1A)-C(2A) 119.94(15) 
C(6A)-C(1A)-S(1A) 122.03(14) 
C(2A)-C(1A)-S(1A) 118.03(13) 
C(3A)-C(2A)-C(1A) 119.74(16) 
C(3A)-C(2A)-S(2A) 122.21(14) 
C(1A)-C(2A)-S(2A) 118.05(12) 
C(4A)-C(3A)-C(2A) 119.95(17) 
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C(4A)-C(3A)-H(3A) 120.0 
C(2A)-C(3A)-H(3A) 120.0 
C(5A)-C(4A)-C(3A) 120.13(17) 
C(5A)-C(4A)-H(4A) 119.9 
C(3A)-C(4A)-H(4A) 119.9 
C(4A)-C(5A)-C(6A) 120.51(17) 
C(4A)-C(5A)-H(5A) 119.7 
C(6A)-C(5A)-H(5A) 119.7 
C(5A)-C(6A)-C(1A) 119.72(18) 
C(5A)-C(6A)-H(6A) 120.1 
C(1A)-C(6A)-H(6A) 120.1 
C(1B)-S(1B)-H(1SB) 96.6(11) 
C(2B)-S(2B)-H(2SB) 97.2(9) 
C(3B)-C(1B)-C(2B) 119.84(15) 
C(3B)-C(1B)-S(1B) 122.14(13) 
C(2B)-C(1B)-S(1B) 118.02(13) 
C(6B)-C(2B)-C(1B) 119.25(16) 
C(6B)-C(2B)-S(2B) 122.68(13) 
C(1B)-C(2B)-S(2B) 118.06(12) 
C(4B)-C(3B)-C(1B) 120.38(17) 
C(4B)-C(3B)-H(3B) 119.8 
C(1B)-C(3B)-H(3B) 119.8 
C(3B)-C(4B)-C(5B) 119.99(17) 
C(3B)-C(4B)-H(4B)    120.0 
C(5B)-C(4B)-H(4B) 120.0 
C(6B)-C(5B)-C(4B) 120.10(16) 
C(6B)-C(5B)-H(5B) 120.0 
C(4B)-C(5B)-H(5B) 120.0 
C(5B)-C(6B)-C(2B) 120.44(16) 
C(5B)-C(6B)-H(6B) 119.8 
C(2B)-C(6B)-H(6B) 119.8 
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Appendix B: List of Symbols and Abbreviations 
General: 
Å angstrom, 10-10 m 
ATP adenosine triphosphate 
DMA(III) dimethylarsinous acid 
DMA(V) dimethylarsinic acid 
EI Electron Impact 
g grams 
GOF goodness of fit 
GSH glutathione, GS 
Hz hertz, s-1 
K Kelvin 
M molar 
M+ molecular ion 
Me methyl, CH3 
mg milligrams 
min minutes 
mL milliliters 
mmol millimoles 
MMA(III) monomethylarsonous acid 
MMA(V) monomethylarsonic acid 
mp melting point 
Ph phenyl 
143 
ppm parts per million 
R R-factor 
Rw weighted R-factor 
s seconds 
t time 
T temperature 
THF tetrahydrofuran 
For nuclear magnetic resonance spectra: 
δ chemical shift (in parts per million) 
d doublet 
m multiplet 
NOE nuclear Overhauser effect 
NMR nuclear magnetic resonance 
s singlet 
For infrared spectra: 
br broad 
cm-1 wavenumbers 
FT-IR Fourier Transform Infrared Spectra 
m medium 
s strong 
ν vibrational frequency (cm-1) 
w weak 
Copyright © Taimur Shaikh 2007 
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